UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED
OR
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM _________________ TO _________________
(Commission file number)
(Exact name of registrant as specified in its charter)
| ||
(State or other jurisdiction of incorporation or organization) | (IRS employer identification number) | |
(Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading symbol(s) |
| Name of each exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section l3 or l5(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ | Accelerated filer ☐ |
Smaller reporting company | |
Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act). ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
The number of shares of the registrant’s Common Stock, par value $0.01 per share, outstanding at October 28, 2022 was
Index
2
Part I - Financial Information
Item 1. Consolidated Financial Statements (Unaudited):
KYNDRYL HOLDINGS, INC.
CONSOLIDATED INCOME STATEMENT
(In millions, except per share amounts)
(Unaudited)
Three Months Ended September 30, | Six Months Ended September 30, | |||||||||||
| 2022 |
| 2021 |
| 2022 |
| 2021 | |||||
Revenues * | $ | | $ | | $ | | $ | | ||||
Cost of services ** | $ | | $ | | $ | | $ | | ||||
Selling, general and administrative expenses | | | | | ||||||||
Workforce rebalancing charges (benefits) | | ( | | ( | ||||||||
Transaction-related costs | | | | | ||||||||
Interest expense | | | | | ||||||||
Other expense (income) | ( | ( | ( | ( | ||||||||
Total costs and expenses | $ | | $ | | $ | | $ | | ||||
Income (loss) before income taxes | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Provision for income taxes | $ | | $ | | $ | | $ | | ||||
Net income (loss) | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Basic earnings (loss) per share | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Diluted earnings (loss) per share | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Weighted-average basic shares outstanding | | | | | ||||||||
Weighted-average diluted shares outstanding | | | | |
* Including related-party revenue of $
** Including related-party cost of services of $
The accompanying notes are an integral part of the financial statements.
3
KYNDRYL HOLDINGS, INC.
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS)
(Dollars in millions)
(Unaudited)
| Three Months Ended September 30, | Six Months Ended September 30, | ||||||||||
| 2022 |
| 2021 | 2022 |
| 2021 | ||||||
Net income (loss) | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Other comprehensive income (loss), before tax: | ||||||||||||
Foreign currency translation adjustments | ( | ( | ( | ( | ||||||||
Unrealized gains (losses) on cash flow hedges: | ||||||||||||
Unrealized gains (losses) arising during the period | — | | ( | | ||||||||
Reclassification of (gains) losses to net income | — | — | ( | — | ||||||||
Total unrealized gains (losses) on cash flow hedges | — | | ( | | ||||||||
Retirement-related benefit plans: | ||||||||||||
Net gains (losses) arising during the period | — | — | — | ( | ||||||||
Amortization of net (gains) losses | | | | | ||||||||
Total retirement-related benefit plans | | | | | ||||||||
Other comprehensive income (loss), before tax | ( | ( | ( | ( | ||||||||
Income tax (expense) benefit related to items of other comprehensive income (loss) | ( | ( | ( | ( | ||||||||
Other comprehensive income (loss), net of tax | ( | ( | ( | ( | ||||||||
Total comprehensive income (loss) | $ | ( | $ | ( | $ | ( | $ | ( |
The accompanying notes are an integral part of the financial statements.
4
KYNDRYL HOLDINGS, INC.
CONSOLIDATED BALANCE SHEET
(In millions, except per share amount)
(Unaudited)
September 30, | March 31, | |||||
| 2022 |
| 2022 | |||
Assets: |
|
| ||||
Current assets: | ||||||
Cash and cash equivalents | $ | | $ | | ||
Restricted cash | | | ||||
Accounts receivable (net of allowances of $ | | | ||||
Deferred costs (current portion) |
| |
| | ||
Prepaid expenses and other current assets | | | ||||
Total current assets | $ | | $ | | ||
Property and equipment, net | $ | | $ | | ||
Operating right-of-use assets, net | | | ||||
Deferred costs (noncurrent portion) | | | ||||
Deferred taxes | | | ||||
Goodwill | | | ||||
Intangible assets, net | | | ||||
Pension assets | | | ||||
Other noncurrent assets | | | ||||
Total assets | $ | | $ | | ||
Liabilities: | ||||||
Current liabilities: | ||||||
Accounts payable** | $ | | $ | | ||
Value-added tax and income tax liabilities | | | ||||
Short-term debt | | | ||||
Accrued compensation and benefits |
| |
| | ||
Deferred income (current portion) |
| |
| | ||
Operating lease liabilities (current portion) |
| |
| | ||
Accrued contract costs | | | ||||
Other accrued expenses and liabilities | | | ||||
Total current liabilities | $ | | $ | | ||
Long-term debt | $ | | $ | | ||
Retirement and nonpension postretirement benefit obligations | | | ||||
Deferred income (noncurrent portion) | | | ||||
Operating lease liabilities (noncurrent portion) | | | ||||
Other noncurrent liabilities | | | ||||
Total liabilities | $ | | $ | | ||
Commitments and contingencies | ||||||
Equity: | ||||||
Stockholders’ equity | ||||||
Common stock, par value $ | $ | | $ | | ||
Accumulated deficit | ( | ( | ||||
Treasury stock, at cost (shares: September 30, 2022 – | ( | ( | ||||
Accumulated other comprehensive income (loss) | ( | ( | ||||
Total stockholders’ equity before non-controlling interests | $ | | $ | | ||
Non-controlling interests | | | ||||
Total equity | $ | | $ | | ||
Total liabilities and equity | $ | | $ | |
* Including related-party accounts receivable of $
** Including related-party accounts payable of $
The accompanying notes are an integral part of the financial statements.
5
KYNDRYL HOLDINGS, INC.
CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
(Unaudited)
Six Months Ended September 30, | ||||||
| 2022 |
| 2021 | |||
Cash flows from operating activities: |
|
|
| |||
Net income (loss) | $ | ( | $ | ( | ||
Adjustments to reconcile net income (loss) to cash provided by operating activities: |
|
| ||||
Depreciation and amortization |
|
| ||||
Depreciation of property and equipment | | | ||||
Depreciation of right-of-use assets | | | ||||
Amortization of transition costs and prepaid software |
| |
| | ||
Amortization of capitalized contract costs | | | ||||
Amortization of intangible assets |
| |
| | ||
Stock-based compensation | | | ||||
Deferred taxes | | ( | ||||
Net (gain) loss on asset sales and other | | ( | ||||
Change in operating assets and liabilities: | ||||||
Deferred costs (excluding amortization) | ( | ( | ||||
Right-of-use assets and liabilities (excluding depreciation) | ( | ( | ||||
Workforce rebalancing liabilities | ( | ( | ||||
Receivables |
|
| ( | |||
Accounts payable | | |||||
Taxes (including items settled with former Parent in prior-year period) | | |||||
Other assets and other liabilities |
| ( |
| ( | ||
Net cash provided by (used in) operating activities | $ | | $ | ( | ||
Cash flows from investing activities: |
|
| ||||
Capital expenditures | $ | ( | $ | ( | ||
Proceeds from disposition of property and equipment |
| |
| | ||
Other investing activities, net | ( | — | ||||
Net cash used in investing activities | $ | ( | $ | ( | ||
Cash flows from financing activities: |
|
| ||||
Debt repayments | $ | ( | $ | ( | ||
Proceeds from issuance of debt, net of debt issuance costs | — | | ||||
Net transfers from Parent | — | | ||||
Common stock repurchases for tax withholdings |
| ( |
| — | ||
Net cash provided by (used in) financing activities | $ | ( | $ | | ||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | $ | ( | $ | ( | ||
Net change in cash, cash equivalents and restricted cash | $ | ( | $ | | ||
Cash, cash equivalents and restricted cash at April 1 | $ | | $ | | ||
Cash, cash equivalents and restricted cash at September 30 | $ | | $ | | ||
Supplemental data | ||||||
Income taxes paid, net of refunds received | $ | | $ | — | ||
Interest paid on debt | $ | | $ | — |
The accompanying notes are an integral part of the financial statements.
6
KYNDRYL HOLDINGS, INC.
CONSOLIDATED STATEMENT OF EQUITY
(In millions)
(Unaudited)
Common Stock and | Accumulated | |||||||||||||||||||||||
Additional | Net | Other | Non- | |||||||||||||||||||||
Paid-In Capital | Parent | Comprehensive | Treasury | Accumulated | Controlling | Total | ||||||||||||||||||
Shares | Amount | Investment | Income (Loss) | Stock | Deficit | Interests | Equity | |||||||||||||||||
Equity – July 1, 2022 | | $ | | $ | — | $ | ( | $ | ( | $ | ( | $ | | $ | | |||||||||
Net income (loss) | ( | ( | ||||||||||||||||||||||
Other comprehensive income (loss), net of tax | ( | ( | ||||||||||||||||||||||
Common stock issued under employee plans | | |||||||||||||||||||||||
Changes in non-controlling interests | | |||||||||||||||||||||||
Equity – September 30, 2022 | $ | $ | — | $ | ( | $ | ( | $ | ( | $ | | $ | |
Common Stock and | Accumulated | |||||||||||||||||||||||
Additional | Net | Other | Non- | |||||||||||||||||||||
Paid-In Capital | Parent | Comprehensive | Treasury | Accumulated | Controlling | Total | ||||||||||||||||||
Shares | Amount | Investment | Income (Loss) | Stock | Deficit | Interests | Equity | |||||||||||||||||
Equity – July 1, 2021 | — | $ | — | $ | | $ | ( | $ | — | $ | — | $ | | $ | | |||||||||
Net income (loss) | ( | ( | ||||||||||||||||||||||
Other comprehensive income (loss), net of tax | ( | ( | ||||||||||||||||||||||
Net transfers from Parent | ( | |||||||||||||||||||||||
Changes in non-controlling interests | ( | ( | ||||||||||||||||||||||
Equity – September 30, 2021 | — | $ | — | $ | $ | ( | $ | — | $ | — | $ | $ |
Common Stock and | Accumulated | |||||||||||||||||||||||
Additional | Net | Other | Non- | |||||||||||||||||||||
Paid-In Capital | Parent | Comprehensive | Treasury | Accumulated | Controlling | Total | ||||||||||||||||||
Shares | Amount | Investment | Income (Loss) | Stock | Deficit | Interests | Equity | |||||||||||||||||
Equity – April 1, 2022 | | $ | | $ | — | $ | ( | $ | ( | $ | ( | $ | | $ | | |||||||||
Net income (loss) | ( | ( | ||||||||||||||||||||||
Other comprehensive income (loss), net of tax | ( | ( | ||||||||||||||||||||||
Common stock issued under employee plans | | |||||||||||||||||||||||
Purchases of treasury stock | ( | ( | ( | |||||||||||||||||||||
Changes in non-controlling interests | | |||||||||||||||||||||||
Equity – September 30, 2022 | $ | $ | — | $ | ( | $ | ( | $ | ( | $ | | $ | |
Common Stock and | Accumulated | |||||||||||||||||||||||
Additional | Net | Other | Non- | |||||||||||||||||||||
Paid-In Capital | Parent | Comprehensive | Treasury | Accumulated | Controlling | Total | ||||||||||||||||||
Shares | Amount | Investment | Income (Loss) | Stock | Deficit | Interests | Equity | |||||||||||||||||
Equity – April 1, 2021 | — | $ | — | $ | | $ | ( | $ | — | $ | — | $ | | $ | | |||||||||
Net income (loss) | ( | ( | ||||||||||||||||||||||
Other comprehensive income (loss), net of tax | ( | ( | ||||||||||||||||||||||
Net transfers from Parent | ( | |||||||||||||||||||||||
Changes in non-controlling interests | ( | ( | ||||||||||||||||||||||
Equity – September 30, 2021 | — | $ | — | $ | $ | ( | $ | — | $ | — | $ | $ |
The accompanying notes are an integral part of the financial statements.
7
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1. SIGNIFICANT ACCOUNTING POLICIES
Description of Business
Kyndryl Holdings, Inc. (“we”, “the Company” or “Kyndryl”) is a leading technology services company and the largest infrastructure services provider in the world, serving as a partner to thousands of enterprise customers whose operations span over
In October 2021, the Board of Directors of IBM approved the spin-off (the “Separation” or the “Spin-off”) of the infrastructure services unit (the “Kyndryl Businesses”) of its Global Technology Services (“GTS”) segment through the distribution of shares of Kyndryl’s common stock to IBM stockholders. In conjunction with the Separation, Kyndryl underwent an internal reorganization following which it became the holder, directly or through its subsidiaries, of the Kyndryl Businesses. On November 3, 2021, the Separation was achieved through the Parent’s pro rata distribution of
Basis of Presentation
Prior to the Separation on November 3, 2021 (the “pre-Separation periods”), our historical financial statements were prepared on a combined basis and were derived from the consolidated financial statements of IBM. For the period subsequent to November 3, 2021, the financial statements are presented on a consolidated basis as the Company became a standalone public company. Management believes the accompanying financial statements include all adjustments necessary to present fairly the Company’s financial position and its results of operations for all the periods presented. The financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the report on Form 8-K/A we filed with the U.S. Securities and Exchange Commission (“SEC”) on May 27, 2022 (the “8-K/A”) and our transition report for the three months ended March 31, 2022 filed on Form 10-QT.
Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages presented are calculated from the underlying whole-dollar amounts. Certain items have been recast to conform to current-period presentation.
Principles of Consolidation
For the pre-Separation periods, the accompanying financial statements were derived from the consolidated financial statements and accounting records of the Parent as if the Company operated on a standalone basis during the periods presented and were prepared in accordance with Generally Accepted Accounting Principles in the United States (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC.
All significant intercompany transactions during the pre-Separation periods between Kyndryl and IBM have been included in the consolidated financial statements. Intercompany transactions between Kyndryl and IBM were considered to be effectively settled in the consolidated financial statements at the time the transaction was recorded. The total net effect of the settlement of these intercompany transactions is reflected as Net transfers from Parent in the financing activities section in the Consolidated Statement of Cash Flows and in the Consolidated Balance Sheet within Net Parent investment.
After the Separation on November 3, 2021, the Company’s consolidated financial statements are based on our reported results as a standalone company. All significant transactions and intercompany accounts between Kyndryl entities were eliminated.
8
Notes to Consolidated Financial Statements (continued)
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect amounts that are reported in the consolidated financial statements and accompanying disclosures. Estimates are used in determining the following, among others: revenue, costs to complete service contracts, income taxes, pension assumptions, valuation of assets including goodwill and intangible assets, the depreciable and amortizable lives of long-lived assets, loss contingencies, allowance for credit losses, deferred transition costs and other matters. Estimates were also used in determining the allocation of costs and expenses from IBM for the pre-Separation periods. These estimates are based on management’s knowledge of current events, historical experience and actions that the Company may undertake in the future and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may be different from these estimates.
Transition Period
In January 2022, the Board of Directors of Kyndryl approved a change to the fiscal year-end of the Company from December 31 to March 31. The Company’s 2023 fiscal year began on April 1, 2022 and will end on March 31, 2023. The Company filed a Transition Report on Form 10-QT for the period of January 1 to March 31, 2022 with the SEC on May 13, 2022.
NOTE 2. ACCOUNTING CHANGES
Standards Implemented
In October 2021, the Financial Accounting Standards Board (“FASB”) issued guidance (“Revenue Contracts with Customers Acquired in a Business Combination”) which requires that an acquirer recognize and measure contract assets and liabilities acquired in a business combination as if the acquirer had originated the contracts, in accordance with ASC 606, Revenue from Contracts with Customers. Deferred revenue acquired in a business combination is no longer required to be measured at its fair value, which had historically resulted in a deferred revenue impairment at the date of acquisition. The guidance is effective January 1, 2023, and early adoption is permitted. The Company has early adopted the guidance as of January 1, 2022. Our adoption did not materially affect our consolidated financial statements.
New Standards to be Implemented
In September 2022, the FASB amended its guidance related to supplier finance programs. The amended guidance requires additional disclosures surrounding the use of supplier finance programs to purchase goods or services, including disclosing the key terms of the programs, the amount of obligations outstanding at the end of the reporting period, and a roll-forward of those obligations. The new guidance, except the roll-forward information, is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The roll-forward information is effective for fiscal years beginning after December 15, 2023. Early adoption is permitted. The Company is currently evaluating the impact that this amended guidance will have on the Company's financial statements.
NOTE 3. REVENUE RECOGNITION
Disaggregation of Revenue
The Company views its segment results to be the best view of disaggregated revenue. Refer to Note 4 – Segments.
Remaining Performance Obligations
The remaining performance obligation (“RPO”) represents the aggregate amount of contractual deliverables yet to be recognized as revenue at the end of the reporting period. It is intended to be a statement of overall work under
9
Notes to Consolidated Financial Statements (continued)
contract that has not yet been performed and does not include contracts in which the customer is not committed. The customer is not considered committed when it is able to terminate for convenience without payment of a substantive penalty. The RPO also includes estimates of variable consideration. Additionally, as a practical expedient, the Company does not include contracts that have an original duration of
At September 30, 2022, the aggregate amount of RPO related to customer contracts that are unsatisfied or partially unsatisfied was $
During the three and six months ended September 30, 2022, revenue was increased by $
Contract Balances
The following table provides information about accounts receivable, contract assets and deferred income balances:
September 30, | March 31, | |||||
(Dollars in millions) |
| 2022 |
| 2022 | ||
Accounts receivable (net of allowances of $ | $ | | $ | | ||
Contract assets ** |
| |
| | ||
Deferred income (current) |
| |
| | ||
Deferred income (noncurrent) |
| |
| |
* | Including unbilled receivable balances of $ |
** | Contract assets represent services performed by the Company prior to billing the client, which give the Company the right to consideration that is typically subject to milestone completion or client acceptance. They are included within prepaid expenses and other current assets in the Consolidated Balance Sheet. |
The amount of revenue recognized during the three and six months ended September 30, 2022 that was included within the deferred income balance at the beginning of the period was $
The following table provides roll-forwards of the accounts receivable allowance for expected credit losses for the six months ended September 30, 2022 and the six months ended September 30, 2021.
Six Months Ended | Six Months Ended | |||||
(Dollars in millions) | September 30, 2022 |
| September 30, 2021 | |||
Beginning balance | $ | | $ | | ||
Additions (releases) | | ( | ||||
Write-offs | ( | ( | ||||
Other * | ( | ( | ||||
Ending balance | $ | | $ | |
* | Primarily represents currency translation adjustments. |
The contract assets allowance for expected credit losses was not material in any of the periods presented.
10
Notes to Consolidated Financial Statements (continued)
Major Clients
No single client represented more than 10 percent of the Company’s total revenue during the three and six months ended September 30, 2022 and 2021. Other than the former Parent (see Note 13 – Related-Party Transactions), no single client represented more than 10 percent of the Company’s total accounts receivable balance as of September 30, 2022 and March 31, 2022.
Deferred Costs
Costs to acquire and fulfill customer contracts are deferred and amortized over the contract period or expected customer relationship life. The expected customer relationship period is determined based on the average customer relationship period, including expected renewals, for each offering type and ranges from
The following table provides amounts of capitalized costs to acquire and fulfill customer contracts at September 30, 2022 and March 31, 2022:
September 30, | March 31, | |||||
(Dollars in millions) |
| 2022 |
| 2022 | ||
Deferred transition costs | $ | | $ | | ||
Prepaid software costs |
| |
| | ||
Capitalized costs to fulfill contracts |
| |
| | ||
Capitalized costs to obtain contracts |
| |
| | ||
Total deferred costs * | $ | | $ | |
* | Of the total deferred costs, $ |
The amount of total deferred costs amortized for the three months ended September 30, 2022 was $
NOTE 4. SEGMENTS
Our reportable segments correspond to how the chief operating decision maker (“CODM”) reviews performance and allocates resources. Our
United States: This reportable segment is comprised of Kyndryl’s operations in the United States.
Japan: This reportable segment is comprised of Kyndryl’s operations in Japan.
Principal Markets: This reportable segment represents the aggregation of our operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain / Portugal, and the United Kingdom / Ireland.
Strategic Markets: This reportable segment is comprised of our operations in all other countries in which we operate.
The measure of segment operating performance used by Kyndryl’s CODM is adjusted EBITDA. Adjusted EBITDA is defined as net income (loss) excluding net interest expense, depreciation and amortization (excluding depreciation of right-of-use assets and amortization of capitalized contract costs), transaction-related costs, pension costs
11
Notes to Consolidated Financial Statements (continued)
other than pension servicing costs and multi-employer plan costs, stock-based compensation expense, workforce rebalancing charges, impairment expense, significant litigation costs, and foreign currency impacts of highly inflationary countries. The use of revenue and adjusted EBITDA aligns with how the CODM assesses performance and allocates resources for the Company’s segments. The Company has recast the prior-period results to reflect the change in segment structure that became effective in the fourth quarter of 2021. In addition, during the three months ended March 31, 2022, the Company updated certain allocation methodologies related to its measure of segment adjusted EBITDA and has accordingly recast the prior-period information to reflect these updates, which did not change the aggregate amount of segment adjusted EBITDA.
Our geographic markets frequently work together to sell and implement certain contracts. The economic environment and its effects on the industries served by our geographic markets affect revenues and operating expenses within our geographic markets to differing degrees. Currency fluctuations also tend to affect our geographic markets differently, depending on the geographic concentrations and locations of their businesses.
The following table reflects the results of the Company’s segments:
Three Months Ended September 30, | Six Months Ended September 30, | |||||||||||
(Dollars in millions) |
| 2022 |
| 2021 |
| 2022 |
| 2021 | ||||
Revenue | ||||||||||||
United States | $ | | $ | | $ | | $ | | ||||
Japan | | | | | ||||||||
Principal Markets | | | | | ||||||||
Strategic Markets | | | | | ||||||||
Total revenue | $ | | $ | | $ | | $ | | ||||
Segment adjusted EBITDA | ||||||||||||
United States | $ | | $ | | $ | | $ | | ||||
Japan | | | | | ||||||||
Principal Markets | | | | | ||||||||
Strategic Markets | | | | | ||||||||
Total segment adjusted EBITDA | $ | | $ | | $ | | $ | |
The following table reconciles consolidated pretax income (loss) to segment adjusted EBITDA:
Three Months Ended September 30, | Six Months Ended September 30, | |||||||||||
(Dollars in millions) |
| 2022 |
| 2021 |
| 2022 |
| 2021 | ||||
Pretax income (loss) | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Workforce rebalancing charges (benefits) | | ( | | ( | ||||||||
Transaction-related costs | | | | | ||||||||
Stock-based compensation expense | | | | | ||||||||
Interest expense | | | | | ||||||||
Depreciation expense | | | | | ||||||||
Amortization expense | | | | | ||||||||
Corporate expense not allocated to the segments | | | | | ||||||||
Other adjustments * | | | | | ||||||||
Segment adjusted EBITDA | $ | | $ | | $ | | $ | |
* Other adjustments represent pension costs other than pension servicing costs and multi-employer plan costs.
NOTE 5. TAXES
For the three months ended September 30, 2022, the Company’s effective tax rate was (
12
Notes to Consolidated Financial Statements (continued)
effective tax rate was (
The Company’s effective tax rate for the three and six months ended September 30, 2022 was lower than the Company’s statutory tax rate primarily due to taxes on foreign operations and an increase in valuation allowances in certain jurisdictions against deferred tax assets that are not more likely than not to be realized. For the three and six months ended September 30, 2022 the additions to valuation allowance primarily relate to a partial valuation allowance established against certain deferred tax assets in the United States.
The Company’s effective tax rate for the three and six months ended September 30, 2021, was lower than the Company’s statutory tax rate primarily due to the geographic mix of pretax income, changes in valuation allowances and tax charges related to the transfer of Kyndryl’s operations from IBM in contemplation of the Company’s Separation.
NOTE 6. NET LOSS PER SHARE
We did
Three Months Ended September 30, | Six Months Ended September 30, | |||||||||||
(In millions, except per share amounts) | 2022 | 2021 | 2022 | 2021 | ||||||||
Net income (loss) on which basic and diluted earnings per share is calculated | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Number of shares on which basic and diluted earnings per share is calculated | | | | | ||||||||
Basic earnings (loss) per share | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Diluted earnings (loss) per share |
| ( | ( |
| ( | ( |
Prior to the Separation, the Company did not have any publicly-traded common stock or equivalents issued and outstanding. Accordingly, the net loss per share for the three and six months ended September 30, 2021 is calculated based on the
For the three and six months ended September 30, 2022, the Company’s basic and diluted weighted-average shares outstanding were the same. The following securities were not included in the computation of diluted net loss per share because they would have been anti-dilutive:
(In millions) | ||
Nonvested restricted stock units issued and outstanding | | |
Nonvested performance-based stock units | | |
Nonvested market-conditioned performance awards | | |
Stock options issued and outstanding | | |
Total | |
13
Notes to Consolidated Financial Statements (continued)
NOTE 7. FINANCIAL ASSETS AND LIABILITIES
Fair Value Measurements
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company classifies certain assets and liabilities based on the following fair value hierarchy:
● | Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities that can be accessed at the measurement date. |
● | Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. |
● | Level 3 – Unobservable inputs for the asset or liability. |
The level of an asset or liability within the fair value hierarchy is determined based on the lowest level of any input that is significant to the fair value measurement.
In determining the fair value of certain financial instruments, the Company considers certain market valuation adjustments to the “base valuations” using the methodologies described below for several parameters that market participants would consider in determining fair value:
● | Counterparty credit risk adjustments are applied to certain financial instruments, taking into account the actual credit risk of a counterparty as observed in the credit default swap market to determine the true fair value of such an instrument. |
● | Credit risk adjustments are applied to reflect the Company’s own credit risk when valuing certain liabilities measured at fair value. The methodology is consistent with that applied in developing counterparty credit risk adjustments, but incorporates the Company’s credit risk as observed in the credit default swap market. |
Certain non-financial assets such as property, plant and equipment, operating right-of-use assets, land, goodwill and intangible assets are recorded at fair value or at cost, as appropriate, in the period they are initially recognized, and such fair value may be adjusted in subsequent periods if an event occurs or circumstances change that indicate that the asset may be impaired. The impairment models used for non-financial assets depend on the type of asset. The fair value measurements, in such instances, would be classified in Level 3 of the fair value hierarchy.
We perform a qualitative assessment of asset impairments on a periodic basis and recognize an impairment if there are sufficient indicators that the fair value is less than carrying value. There were
Financial Assets and Liabilities Measured at Fair Value
The gross balances of derivative assets contained within prepaid expenses and other current assets in the Consolidated Balance Sheet were $
14
Notes to Consolidated Financial Statements (continued)
The Company may enter into master netting agreements with certain counterparties that allow for netting of exposures in the event of default or breach. However, in the Consolidated Balance Sheet, the Company does not offset derivative assets against liabilities with counterparties in master netting arrangements by counterparty, and there was
Financial Assets and Liabilities Not Measured at Fair Value
Accounts receivable are financial assets with carrying values that approximate fair value. Accounts payable, other accrued expenses and short-term debt are financial liabilities with carrying values that approximate fair value. If measured at fair value in the consolidated financial statements, these financial instruments would be classified as Level 3 in the fair value hierarchy, except for short-term debt, which would be classified as Level 2.
The Company has time deposits that have maturities of 90 days or less, and their carrying values approximate fair value. The balance of these time deposits with maturities of 90 days or less contained within cash and cash equivalents in the Consolidated Balance Sheet at September 30, 2022 and March 31, 2022 was $
The fair value of our outstanding debt (excluding finance lease obligations) is based on various methodologies, including quoted prices in active markets for identical debt instruments, which is a Level 1 measurement, and calculated fair value using an expected present value technique that uses rates currently available to the Company for debt in active markets with similar terms and remaining maturities, which is a Level 2 measurement. Our outstanding debt (excluding finance lease obligations) had a carrying value of $
Financial assets are measured for impairment on a recurring basis by comparing their fair value with their amortized cost basis. There were
Transfers of Financial Assets
The Company has entered into arrangements with third-party financial institutions to sell certain financial assets (primarily trade receivables) without recourse. The Company determined these are true sales, derecognized the carrying value of the financial asset transferred and recognized a net gain or loss on the sale. The proceeds from these arrangements are reflected as cash provided by operating activities in the Consolidated Statement of Cash Flows. Proceeds from receivables sold to third parties under this program were $
Derivative Financial Instruments
Foreign Exchange Risk
Anticipated Cost Transactions
The Company has foreign exchange derivative financial instruments designated as cash flow hedges to manage foreign currency risk. Changes in fair value of derivatives designated as cash flow hedges are recorded, net of applicable taxes, in other comprehensive income and subsequently reclassified into the same income statement line item as the hedged exposure when the underlying hedged item is recognized in earnings. The cash flows associated with derivatives designated as cash flow hedges are reported in cash flows from operating activities in the Consolidated Statement of
15
Notes to Consolidated Financial Statements (continued)
Cash Flows. Through the pre-Separation periods, derivatives designated as cash flow hedges were deemed to be associated with the Company’s operations and were allocated to the Company’s Consolidated Income Statement based on its pro rata share of the underlying items hedged, where applicable, with the remainder allocated on a pro rata basis of revenue.
At September 30, 2022 and March 31, 2022, the total notional amount of forward contracts designated as cash flow hedges of forecasted foreign currency cost transactions was $
At September 30, 2022, in connection with cash flow hedges of foreign currency cost transactions, the Company had net deferred losses of $
Subsidiary Cash and Foreign Currency Asset / Liability Management
The Company uses global treasury centers to manage the cash of its subsidiaries. These centers principally use currency swaps to convert cash flows in a cost-effective manner. Changes in fair value of derivatives not designated as hedges are reported in earnings in other (income) and expense. Cash flows from derivatives not designated as hedges are reported in cash flows from investing activities in the Consolidated Statement of Cash Flows. The terms of these swap contracts are generally less than
The Effect of Derivative Instruments in the Consolidated Income Statement
The total amounts of income and expense line items presented in the Consolidated Income Statement in which the effects of cash flow hedges and derivatives not designated as hedging instruments are recorded, and the total effect of hedge activity on these income and expense line items are as follows:
Gains (Losses) from | ||||||||||||
(Dollars in millions) | Total | Hedge Activity | ||||||||||
For the three months ended September 30: |
| 2022 |
| 2021 |
| 2022 |
| 2021 | ||||
Cost of services | $ | | $ | | $ | — | $ | — | ||||
Selling, general and administrative expenses | | | — | — | ||||||||
Other expense (income) | ( | ( | ( | — |
Gain (Loss) Recognized in Consolidated Income Statement | ||||||||||||||
(Dollars in millions) | Consolidated | Recognized on | Attributable to Risk | |||||||||||
For the three months | Income Statement | Derivatives | Being Hedged | |||||||||||
ended September 30: |
| Line Item | 2022 |
| 2021 |
| 2022 |
| 2021 | |||||
Derivative instruments not designated as hedging instruments: | ||||||||||||||
Foreign exchange contracts | $ | ( | $ | — | NA | NA | ||||||||
Total |
| $ | ( | $ | — | $ | — | $ | — |
NA - not applicable
16
Notes to Consolidated Financial Statements (continued)
Gains (Losses) from | ||||||||||||
(Dollars in millions) | Total | Hedge Activity | ||||||||||
For the six months ended September 30: |
| 2022 |
| 2021 |
| 2022 |
| 2021 | ||||
Cost of services | $ | | $ | | $ | | $ | — | ||||
Selling, general and administrative expenses | | | — | — | ||||||||
Other expense (income) | ( | ( | ( | — |
Gain (Loss) Recognized in Consolidated Income Statement | ||||||||||||||
(Dollars in millions) | Consolidated | Recognized on | Attributable to Risk | |||||||||||
For the six months | Income Statement | Derivatives | Being Hedged | |||||||||||
ended September 30: |
| Line Item | 2022 |
| 2021 |
| 2022 |
| 2021 | |||||
Derivative instruments not designated as hedging instruments: | ||||||||||||||
Foreign exchange contracts | $ | ( | $ | — | NA | NA | ||||||||
Total |
| $ | ( | $ | — | $ | — | $ | — |
Gain (Loss) Recognized in Consolidated Income Statement and Other Comprehensive Income | ||||||||||||||
(Dollars in millions) | Recognized | Consolidated | Reclassified | |||||||||||
For the six months | in OCI | Income Statement | from AOCI | |||||||||||
ended September 30: |
| 2022 |
| 2021 |
| Line Item |
| 2022 |
| 2021 | ||||
Derivative instruments in cash flow hedges: |
|
|
| |||||||||||
Foreign exchange contracts | $ | ( | $ | — | Cost of services | $ | $ | — | ||||||
Selling, general and administrative expenses | — | — | ||||||||||||
Other expense (income) | — | — | ||||||||||||
Total | $ | ( | $ | — |
| $ | | $ | — |
NA - not applicable
For the three and six months ended September 30, 2022 and 2021, there were
Prior to the third quarter of 2021, Kyndryl did not independently execute derivative financial instruments to manage its foreign currency risk and instead participated in a centralized foreign currency hedging program administered by IBM. The hedging activity allocated to Kyndryl was for the former Parent’s forecasted currency exposures. In the third quarter of 2021, we began to execute trades to hedge certain of the Company’s foreign exchange exposures.
17
Notes to Consolidated Financial Statements (continued)
NOTE 8. INTANGIBLE ASSETS INCLUDING GOODWILL
Business Combinations
On February 1, 2022, the Company completed
The following table summarizes total consideration transferred, fair value of net assets acquired, net liabilities assumed and goodwill for the Exa transaction:
March 31, | |||
(Dollars in millions) | 2022 | ||
Cash consideration | $ | | |
Non-controlling interest | | ||
Total enterprise value | $ | | |
Cash acquired | $ | | |
Net liabilities assumed, excluding cash | ( | ||
Deferred tax liabilities arising from acquired intangibles | ( | ||
Intangible assets * | | ||
Goodwill | | ||
Total purchase price allocation | $ | |
* Intangible assets acquired consist of $
Intangible Assets
The following tables present the Company’s intangible asset balances by major asset class.
At September 30, 2022 | At March 31, 2022 | |||||||||||||||||
| Gross Carrying |
| Accumulated |
| Net Carrying |
| Gross Carrying |
| Accumulated |
| Net Carrying | |||||||
(Dollars in millions) |
| Amount |
| Amortization |
| Amount |
| Amount |
| Amortization |
| Amount | ||||||
Capitalized software | $ | | $ | ( | $ | | $ | | $ | ( | $ | | ||||||
Customer relationships* | | ( | | | ( | | ||||||||||||
Completed technology |
| |
| ( |
| — |
| |
| ( |
| — | ||||||
Patents and trademarks* |
| |
| ( |
| |
| |
| ( |
| | ||||||
Total | $ | | $ | ( | $ | | $ | | $ | ( | $ | |
* Amounts at September 30, 2022 include effects from foreign currency translation.
The net carrying amount of intangible assets decreased by $
18
Notes to Consolidated Financial Statements (continued)
three and six months ended September 30, 2021. The amortization expense for these periods all relate to assets acquired via business combinations.
The future amortization expense relating to intangible assets currently recorded in the Consolidated Balance Sheet was estimated to be the following at September 30, 2022:
Capitalized | Customer | Patents and | ||||||||||
(Dollars in millions) | Software |
| Relationships | Trademarks | Total | |||||||
Year ending March 31: | ||||||||||||
2023 (remaining six months) | $ | | $ | $ | $ | |||||||
2024 | |
| ||||||||||
2025 | |
| ||||||||||
2026 | |
| ||||||||||
2027 | |
| ||||||||||
Thereafter | | — |
|
Goodwill
The changes in the goodwill balances by segment for the six months ended September 30, 2022 were as follows:
Additions and | |||||||||
(Dollars in millions) | Balance at | Other | Balance at | ||||||
Segment | March 31, 2022 | Adjustments* |
| September 30, 2022 | |||||
United States | $ | — | $ | — | $ | — | |||
Japan | | ( | | ||||||
Principal Markets |
| |
| — |
| | |||
Strategic Markets |
| |
| — |
| | |||
Total | $ | | $ | ( | $ | |
* Primarily related to foreign currency translation.
Management reviews goodwill for impairment annually during the fourth quarter of the fiscal year and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable by first assessing qualitative factors to determine if it is more likely than not that fair value is less than carrying value. There were
19
Notes to Consolidated Financial Statements (continued)
NOTE 9. BORROWINGS
Debt
The following table presents the components of our debt:
|
| September 30, | March 31, | |||||||
(Dollars in millions) | Interest Rate | Maturity | 2022 | 2022 | ||||||
Unsecured floating-rate term loan | November 2024 | $ | | $ | | |||||
Commercial loan agreement | July 2026 | | | |||||||
Unsecured senior notes due 2026 | October 2026 | | | |||||||
Unsecured senior notes due 2028 | October 2028 | | | |||||||
Unsecured senior notes due 2031 | October 2031 | | | |||||||
Unsecured senior notes due 2041 | October 2041 | | | |||||||
Finance lease obligations ** | 2022-2027 | | | |||||||
$ | | $ | | |||||||
Less: Unamortized discount | | | ||||||||
Less: Unamortized debt issuance costs |
|
| | | ||||||
Less: Current maturities of long-term debt |
|
| | | ||||||
Total long-term debt |
|
| $ | | $ | |
* Floating rate calculated as of September 30, 2022, using a rate equal to one-month U.S. dollar LIBOR plus
** Finance lease obligations presented using the weighted-average interest rate and calendar-year maturity dates.
Contractual obligations of long-term debt outstanding at September 30, 2022, exclusive of finance lease obligations, are as follows:
(Dollars in millions)* |
| Principal | |
Year ending March 31: | |||
2023 (remaining six months) | $ | | |
2024 |
| | |
2025 |
| | |
2026 |
| | |
2027 | | ||
Thereafter |
| | |
Total | $ | |
* Contractual obligations approximate scheduled repayments.
Revolving Credit Agreement
In October 2021, we entered into a $
The Revolving Credit Agreement expires, unless extended, in October 2026. Interest rates on borrowings under the Revolving Credit Agreements are based on prevailing market interest rates, plus a margin, as further described in the Revolving Credit Agreement. The total expense recorded by the Company for the Revolving Credit Agreement was not material in any of the periods presented.
We may voluntarily prepay borrowings under the Revolving Credit Agreement without premium or penalty, subject to customary “breakage” costs. The Revolving Credit Agreement includes certain customary mandatory prepayment provisions.
20
Notes to Consolidated Financial Statements (continued)
Interest on Debt
Interest expense for the three and six months ended September 30, 2022 was $
NOTE 10. COMMITMENTS AND CONTINGENCIES
The Company guarantees certain loans and financial commitments. The maximum potential future payment under these financial guarantees and the fair value of these guarantees recognized in the Consolidated Balance Sheet at September 30, 2022 and March 31, 2022 were not material. Additionally, the Company has contractual commitments that are noncancellable with certain software, hardware and cloud partners used in the delivery of services to customers. Certain of these commitments were allocated to the Company as part of the Separation from its former Parent. The Company has determined that these commitments may exceed the Company’s needs over the next
As a company with approximately
The Company records a provision with respect to a claim, suit, investigation or proceeding when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. In accordance with the relevant accounting guidance, the Company provides disclosures of matters for which the likelihood of material loss is at least reasonably possible. In addition, the Company may also disclose matters based on its consideration of other matters and qualitative factors, including the experience of other companies in the industry, and investor, customer and employee relations considerations.
The Company reviews claims, suits, investigations and proceedings at least quarterly, and decisions are made with respect to recording or adjusting provisions and disclosing reasonably possible losses or range of losses (individually or in the aggregate) to reflect the impact and status of settlement discussions, discovery, procedural and substantive rulings, reviews by counsel and other information pertinent to a particular matter.
Whether any losses, damages or remedies finally determined in any claim, suit, investigation or proceeding could reasonably have a material effect on the Company’s business, financial condition, results of operations or cash flows will depend on a number of variables, including the timing and amount of such losses or damages; the structure and type of any such remedies; the significance of the impact any such losses, damages or remedies may have in the
21
Notes to Consolidated Financial Statements (continued)
consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors. While the Company will continue to defend itself vigorously, it is possible that the Company’s business, financial condition, results of operations or cash flows could be affected in any particular period by the resolution of one or more of these matters.
In July 2017, BMC Software, Inc. (“BMC”) filed suit against IBM in the U.S. Court for the Southern District of Texas in a dispute involving various aspects of IBM’s business, including its managed infrastructure business. BMC alleged IBM’s removal of BMC software from one of its client’s sites at the client’s request constituted breach of contract, fraudulent inducement and trade secret misappropriation. In May 2022, the trial court entered a judgment against IBM and awarded BMC $
Separately, certain contractual disputes have arisen between Kyndryl and IBM. IBM and Kyndryl have commenced arbitration proceedings related to certain of these matters. Kyndryl intends to vigorously pursue its interests and defenses in these matters, including asserting its own claims in arbitration if necessary.
NOTE 11. EQUITY
The following tables present reclassifications and taxes related to items of other comprehensive income (loss) for the three and six months ended September 30, 2022 and 2021:
| Pretax |
| Tax (Expense) |
| Net of Tax | ||||
(Dollars in millions) |
| Amount |
| Benefit |
| Amount | |||
For the three months ended September 30, 2022: | |||||||||
Foreign currency translation adjustments | $ | ( | $ | — | $ | ( | |||
Retirement-related benefit plans*: |
|
|
| ||||||
Amortization of net (gains) losses | $ | | $ | ( | $ | | |||
Total retirement-related benefit plans | $ | | $ | ( | $ | | |||
Other comprehensive income (loss) | $ | ( | $ | ( | $ | ( | |||
For the three months ended September 30, 2021: |
| ||||||||
Foreign currency translation adjustments | $ | ( | $ | — | $ | ( | |||
Unrealized gains (losses) on cash flow hedges: | |||||||||
Unrealized gains (losses) arising during the period | $ | | $ | — | $ | | |||
Total unrealized gains (losses) on cash flow hedges | $ | | $ | — | $ | | |||
Retirement-related benefit plans*: |
|
|
| ||||||
Amortization of net (gains) losses | $ | | $ | ( | $ | | |||
Total retirement-related benefit plans | $ | | $ | ( | $ | | |||
Other comprehensive income (loss) | $ | ( | $ | ( | $ | ( |
* | These AOCI components are included in the computation of net periodic benefit cost. Refer to Note 12 – Retirement-Related Benefits for additional information. |
22
Notes to Consolidated Financial Statements (continued)
| Pretax |
| Tax (Expense) |
| Net of Tax | ||||
(Dollars in millions) |
| Amount |
| Benefit |
| Amount | |||
For the six months ended September 30, 2022: | |||||||||
Foreign currency translation adjustments | $ | ( | $ | — | $ | ( | |||
Unrealized gains (losses) on cash flow hedges: | |||||||||
Unrealized gains (losses) arising during the period | $ | ( | $ | | $ | ( | |||
Reclassification of (gains) losses to net income | ( | — | ( | ||||||
Total unrealized gains (losses) on cash flow hedges | $ | ( | $ | | $ | ( | |||
Retirement-related benefit plans*: |
|
|
| ||||||
Amortization of net (gains) losses | $ | | $ | ( | $ | | |||
Total retirement-related benefit plans | $ | | $ | ( | $ | | |||
Other comprehensive income (loss) | $ | ( | $ | ( | $ | ( | |||
For the six months ended September 30, 2021: |
| ||||||||
Foreign currency translation adjustments | $ | ( | $ | — | $ | ( | |||
Unrealized gains (losses) on cash flow hedges: | |||||||||
Unrealized gains (losses) arising during the period | $ | | $ | — | $ | | |||
Total unrealized gains (losses) on cash flow hedges | $ | | $ | — | $ | | |||
Retirement-related benefit plans*: |
|
|
| ||||||
Net (losses) gains arising during the period | $ | ( | $ | | $ | ( | |||
Amortization of net (gains) losses |
| | ( | | |||||
Total retirement-related benefit plans | $ | | $ | ( | $ | | |||
Other comprehensive income (loss) | $ | ( | $ | ( | $ | ( |
* | These AOCI components are included in the computation of net periodic benefit cost. Refer to Note 12 – Retirement-Related Benefits for additional information. |
23
Notes to Consolidated Financial Statements (continued)
The following tables present the components of accumulated other comprehensive income (loss), net of taxes:
Net Unrealized | Foreign | Net Change | Accumulated | |||||||||
Gain (Losses) | Currency | Retirement- | Other | |||||||||
on Cash | Translation | Related | Comprehensive | |||||||||
(Dollars in millions) |
| Flow Hedges | Adjustments* |
| Benefit Plans | Income (Loss) | ||||||
July 1, 2022 | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Other comprehensive income (loss)** | — | ( | | ( | ||||||||
September 30, 2022 | $ | ( | $ | ( | $ | ( | $ | ( | ||||
July 1, 2021 | $ | — | $ | ( | $ | ( | $ | ( | ||||
Net transfers from Parent | — | — | ( | ( | ||||||||
Other comprehensive income (loss)** | | ( | | ( | ||||||||
September 30, 2021 | $ | | $ | ( | $ | ( | $ | ( |
Net Unrealized | Foreign | Net Change | Accumulated | |||||||||
Gain (Losses) | Currency | Retirement- | Other | |||||||||
on Cash | Translation | Related | Comprehensive | |||||||||
(Dollars in millions) |
| Flow Hedges | Adjustments* |
| Benefit Plans | Income (Loss) | ||||||
April 1, 2022 | $ | | $ | ( | $ | ( | $ | ( | ||||
Other comprehensive income (loss)** | ( | ( | | ( | ||||||||
September 30, 2022 | $ | ( | $ | ( | $ | ( | $ | ( | ||||
April 1, 2021 | $ | — | $ | ( | $ | ( | $ | ( | ||||
Net transfers from Parent | — | — | ( | ( | ||||||||
Other comprehensive income (loss)** | | ( | | ( | ||||||||
September 30, 2021 | $ | | $ | ( | $ | ( | $ | ( |
* | Foreign currency translation adjustments are presented gross. |
** | No amounts were reclassified from accumulated other comprehensive income. |
24
Notes to Consolidated Financial Statements (continued)
NOTE 12. RETIREMENT-RELATED BENEFITS
The following table presents the components of net periodic benefit cost for the retirement-related benefit plans recognized in the Consolidated Income Statement, excluding defined contribution plans, for the three and six months ended September 30, 2022 and 2021.
(Dollars in millions) | Defined Benefit Pension Plans | Nonpension Postretirement Benefit Plans | ||||||||||
For the three months ended September 30: |
| 2022 |
| 2021 |
| 2022 |
| 2021 | ||||
Service cost |
| $ | |
| $ | |
| $ | — |
| $ | |
| |
| |
| — |
| — | |||||
| ( |
| ( |
| — |
| — | |||||
| |
| |
| — |
| — | |||||
Multi-employer plans and other costs(2) |
| |
| |
| — |
| — | ||||
Net periodic benefit cost |
| $ | |
| $ | |
| $ | — |
| $ | |
(Dollars in millions) | Defined Benefit Pension Plans | Nonpension Postretirement Benefit Plans | ||||||||||
For the six months ended September 30: |
| 2022 |
| 2021 |
| 2022 |
| 2021 | ||||
Service cost |
| $ | |
| $ | |
| $ | — |
| $ | |
| |
| |
| — |
| — | |||||
| ( |
| ( |
| — |
| ( | |||||
| |
| |
| — |
| — | |||||
Multi-employer plans and other costs(2) |
| |
| |
| — |
| — | ||||
Net periodic benefit cost |
| $ | |
| $ | |
| $ | — |
| $ | |
(1) | These components of net periodic benefit cost are included in other expense (income) in the Consolidated Income Statement. |
(2) | Multi-employer plan costs represent required contributions for the period to multi-employer plans, which are plans sponsored by third parties. The Company recognizes expense in connection with multi-employer plans as operating costs as contributions are funded. |
The Company estimates contributions to its defined benefit pension plans, multi-employer plans and nonpension postretirement benefit plans for fiscal year 2023 to be approximately $
NOTE 13. RELATED-PARTY TRANSACTIONS
Change in Beneficial Ownership
Based on IBM’s Quarterly Reports filed with the SEC on July 25, 2022 and October 25, 2022, IBM transferred all of its
Related-Party Revenue and Purchases
Kyndryl provides various services to IBM, including those related to hosting data centers and servicing IBM’s information technology infrastructure, which are reported as revenue in the Company’s Consolidated Income Statement. Revenue generated from these services was $
25
Notes to Consolidated Financial Statements (continued)
Kyndryl utilizes various IBM products and services, recognized as costs of services, in the fulfillment of services contracts. Total cost of services recognized from these related-party transactions in the Company’s Consolidated Income Statement was $
Capital Expenditures with Former Parent
Capital expenditures for purchases of IBM hardware were reflected as payments for property and equipment within the investing section of the Company’s Consolidated Statement of Cash Flows in the amounts of $
Related Party Agreements
On November 2, 2021, in connection with the Separation, the Company entered into several agreements with IBM that govern the relationship of the parties following the Separation. Such agreements were described in our 2021 Annual Report.
Allocation of Corporate Expenses
Post-Separation, general corporate expenses from IBM were no longer allocated to Kyndryl; therefore,
Prior to the Separation, IBM allocated certain general corporate expenses that would have been incurred by Kyndryl had it been a separate, standalone company. These allocated general corporate expenses from IBM were recorded in the historical Consolidated Income Statement, Consolidated Statement of Comprehensive Income (Loss) and Consolidated Statement of Cash Flows. Allocations for management costs and corporate support services provided to Kyndryl for the three months ended September 30, 2021 totaled $
26
Notes to Consolidated Financial Statements (continued)
represents expenses for corporate functions including, but not limited to, senior management, legal, human resources, finance and accounting, treasury, information technology and other shared services. All such amounts have been deemed to have been incurred and settled by Kyndryl through net Parent investment in the period in which the costs were recorded. These costs were allocated based on direct usage as applicable, with the remainder allocated on a pro-rata basis of gross profit, headcount, assets or other measures.
Net Parent Investment
As a result of the Separation, net Parent investment in the Consolidated Balance Sheet and Consolidated Statement of Equity was fully settled on November 3, 2021. As such, there was
Prior to the Separation, net Parent investment in the historical Balance Sheet and Statement of Equity represented IBM’s historical investment in Kyndryl, the net effect of transactions with and allocations from IBM, and Kyndryl’s accumulated earnings. The net Parent investment balance at September 30, 2021 was $
Lease Guarantees
Kyndryl has
NOTE 14. REVISION OF PRIOR-PERIOD FINANCIAL STATEMENTS
During the three months ended March 31, 2022, the Company identified and corrected an $
27
Notes to Consolidated Financial Statements (continued)
A summary of the impact of the revision to the accompanying prior-period consolidated financial statements is presented in the tables below.
(Dollars in millions) | Three Months Ended September 30, 2021 | ||||||||
Consolidated Income Statement |
| As Previously Reported |
| Adjustments |
| As Revised | |||
Cost of services | $ | | $ | ( | $ | | |||
Total costs and expenses | | ( | | ||||||
Income (loss) before income taxes | ( | | ( | ||||||
Provision for income taxes | | | | ||||||
Net income (loss) | ( | | ( |
(Dollars in millions) | Six Months Ended September 30, 2021 | ||||||||
Consolidated Income Statement |
| As Previously Reported |
| Adjustments |
| As Revised | |||
Cost of services | $ | | $ | ( | $ | | |||
Total costs and expenses | | ( | | ||||||
Income (loss) before income taxes | ( | | ( | ||||||
Provision for income taxes | | | | ||||||
Net income (loss) | ( | | ( |
(Dollars in millions) | Three Months Ended September 30, 2021 | ||||||||
Consolidated Statement of Comprehensive Income (Loss) |
| As Previously Reported |
| Adjustments |
| As Revised | |||
Net income (loss) | $ | ( | $ | | $ | ( | |||
Foreign currency translation adjustments | ( | ( | ( | ||||||
Other comprehensive income (loss), before tax | ( | ( | ( | ||||||
Other comprehensive income (loss), net of tax | ( | ( | ( | ||||||
Total comprehensive income (loss) | ( | — | ( |
(Dollars in millions) | Six Months Ended September 30, 2021 | ||||||||
Consolidated Statement of Comprehensive Income (Loss) |
| As Previously Reported |
| Adjustments |
| As Revised | |||
Net income (loss) | $ | ( | $ | | $ | ( | |||
Foreign currency translation adjustments | ( | ( | ( | ||||||
Other comprehensive income (loss), before tax | ( | ( | ( | ||||||
Other comprehensive income (loss), net of tax | ( | ( | ( | ||||||
Total comprehensive income (loss) | ( | | ( |
(Dollars in millions) | At September 30, 2021 | ||||||||
Consolidated Balance Sheet |
| As Previously Reported |
| Adjustments |
| As Revised | |||
Accrued contract costs | $ | | $ | ( | $ | | |||
Total current liabilities | | ( | | ||||||
Other liabilities | | | | ||||||
Total liabilities | | ( | | ||||||
Net Parent investment | | | | ||||||
Accumulated other comprehensive income/(loss) | ( | | ( | ||||||
Total Net Parent investment | | | | ||||||
Total equity | | | |
28
Notes to Consolidated Financial Statements (continued)
(Dollars in millions) | Six Months Ended September 30, 2021 | ||||||||
Consolidated Statement of Cash Flows |
| As Previously Reported |
| Adjustments |
| As Revised | |||
Cash flows from operating activities: | |||||||||
Net income (loss) | $ | ( | $ | | $ | ( | |||
Adjustments to reconcile net income (loss) to cash provided by operating activities: |
| ||||||||
Taxes (including items settled with former Parent) | | | | ||||||
Other assets and other liabilities | ( |
| ( | ( |
(Dollars in millions) | At March 31, 2021 | ||||||||
Consolidated Statement of Equity |
| As Previously Reported |
| Adjustments |
| As Revised | |||
Net Parent investment | $ | | $ | | $ | | |||
Accumulated other comprehensive income/(loss) | ( | | ( | ||||||
Total Net Parent investment | | | | ||||||
Total equity | | | |
(Dollars in millions) | At June 30, 2021 | ||||||||
Consolidated Statement of Equity |
| As Previously Reported |
| Adjustments |
| As Revised | |||
Net Parent investment | $ | | $ | | $ | | |||
Accumulated other comprehensive income/(loss) | ( | | ( | ||||||
Total Net Parent investment | | | | ||||||
Total equity | | | |
(Dollars in millions) | At September 30, 2021 | ||||||||
Consolidated Statement of Equity |
| As Previously Reported |
| Adjustments |
| As Revised | |||
Net Parent investment | $ | | $ | | $ | | |||
Accumulated other comprehensive income/(loss) | ( | | ( | ||||||
Total Net Parent investment | | | | ||||||
Total equity | | | |
29
Item 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2022
Overview
Three Months Ended September 30, | Six Months Ended September 30, | |||||||||||||||
(Dollars in millions) |
| 2022 | 2021 |
| 2022 | 2021 | ||||||||||
Revenue | $ | 4,179 | $ | 4,579 | $ | 8,467 | $ | 9,330 | ||||||||
Revenue growth (GAAP) | (9) | % | (6) | % | (9) | % | (3) | % | ||||||||
Revenue growth in constant currency(1) | 1 | % |
| (6) | % | (1) | % |
| (5) | % | ||||||
Net income (loss) | $ | (281) | $ | (690) | $ | (531) | $ | (1,079) | ||||||||
Adjusted EBITDA(1) | $ | 428 | $ | 501 | $ | 919 | $ | 1,072 |
(1) Revenue growth in constant currency and adjusted EBITDA are non-GAAP financial metrics. For definitions of these metrics and a reconciliation of adjusted EBITDA to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP, see “⸺Segment Results.”
| September 30, | March 31, | ||||
(Dollars in millions) |
| 2022 |
| 2022 | ||
Assets | $ | 11,629 | $ | 13,442 | ||
Liabilities | 9,882 | 10,730 | ||||
Equity | 1,746 | 2,711 |
Organization of Information
Kyndryl Holdings, Inc. was formed as a wholly-owned subsidiary of IBM in September 2021 to hold the operations of the managed infrastructure services unit of IBM’s Global Technology Services segment. On November 3, 2021, IBM distributed shares representing 80.1% of Kyndryl’s outstanding common stock to holders of record of IBM’s common stock as of the close of business on October 25, 2021 in a spin-off that is tax-free for U.S. federal tax purposes. Following the distribution, Kyndryl became an independent, publicly-traded company and is the world’s leading managed infrastructure services provider. Based on IBM’s Quarterly Reports filed with the SEC on July 25, 2022 and October 25, 2022, as of September 30, 2022, IBM had transferred all of its 19.9% retained interest in Kyndryl common stock pursuant to exchange agreements with a third-party financial institution.
Kyndryl utilized allocations and carve-out methodologies through November 3, 2021 to prepare historical financial statements. The consolidated financial statements for the pre-Separation periods herein may not be indicative of our future performance, do not necessarily include the actual expenses that would have been incurred by us and may not reflect our results of operations, financial position and cash flows had we been a separate, standalone company during the historical periods presented. For additional information, see “Basis of Presentation” in Note 1 – Significant Accounting Policies in the accompanying Consolidated Financial Statements.
Financial Performance Summary
Macro Dynamics
In 2021, we saw a broad-based macroeconomic recovery in most regions of the world. Demand for technology services rebounded, as large organizations again demonstrated a need for assistance in designing, building, managing and modernizing their technology systems. Thus far in 2022, we have seen continuing demand for information technology services, as well as, declining economic growth, increased geopolitical tensions, lingering effects of the COVID-19 pandemic, inflationary pressures and government efforts to stem inflation. Although the risk of economic
30
Management Discussion (continued)
slowdowns in certain geographies has recently increased, most economists, including the International Monetary Fund, expect positive global macroeconomic growth in 2022 and 2023.
Financial Performance
For the three months ended September 30, 2022, we reported $4.2 billion in revenue, a decline of 9 percent when compared to the prior-year period, primarily driven by a 10-point negative impact from currency. United States revenue declined 2 percent, Japan revenue declined 16 percent, Principal Markets revenue declined 16 percent and Strategic Markets revenue increased 2 percent compared to the three months ended September 30, 2021. Net loss of $281 million improved by $409 million versus the prior year, primarily driven by lower tax expense, transaction-related costs and cost of services as a percentage of revenue.
For the six months ended September 30, 2022, we reported $8.5 billion in revenue, a decline of 9 percent when compared to the prior-year period, primarily driven by an 8-point negative impact from currency. United States revenue declined 3 percent, Japan revenue declined 15 percent, Principal Markets revenue declined 17 percent and Strategic Markets revenue increased 2 percent compared to the six months ended September 30, 2021. Net loss of $531 million improved by $548 million versus the prior year, primarily driven by lower tax expense, transaction-related costs and cost of services as a percentage of revenue.
Segment Results
In the fourth quarter of 2021, the Company implemented a new operating model and reporting structure resulting in four reportable segments: United States, Japan, Principal Markets and Strategic Markets. Principal Markets consists of our operations in Australia/New Zealand, Canada, France, Germany, Italy, India, Spain/Portugal and United Kingdom/Ireland. Strategic Markets consists of our operations in all other countries in which we operate. In addition to this change, the measures of segment operating performance changed to revenue and adjusted EBITDA. The Company has recast the prior-period results to reflect this change in segment structure. During the three months ended March 31, 2022, the Company updated certain allocation methodologies among segments related to its measure of adjusted EBITDA and has accordingly recast the prior-period information to reflect these updates, which did not change the aggregate amount of adjusted EBITDA. See Note 14 – Revision of Prior-Period Financial Statements regarding immaterial revisions we made to the historical periods.
31
Management Discussion (continued)
The following table presents our reportable segments’ revenue and adjusted EBITDA for the three and six months ended September 30, 2022 and 2021 and has incorporated the aforementioned updates in the historical periods presented. Segment revenue and revenue growth in constant currency exclude any transactions between the segments.
| Three Months Ended | Year-over- |
| Six Months Ended | Year-over- | |||||||||||||||||
September 30, | Year Change | September 30, | Year Change | |||||||||||||||||||
(Dollars in millions) |
| 2022 | 2021 | 2022 vs. 2021 |
| 2022 | 2021 | 2022 vs. 2021 | ||||||||||||||
Revenue | ||||||||||||||||||||||
United States | $ | 1,149 | $ | 1,175 | (2) | % | $ | 2,317 | $ | 2,384 | (3) | % | ||||||||||
Japan | 614 | 730 | (16) | % | 1,249 | 1,477 | (15) | % | ||||||||||||||
Principal Markets | 1,472 | 1,748 | (16) | % | 2,988 | 3,590 | (17) | % | ||||||||||||||
Strategic Markets | 944 | 926 | 2 | % | 1,914 | 1,879 | 2 | % | ||||||||||||||
Total revenue | $ | 4,179 | $ | 4,579 | (9) | % | $ | 8,467 | $ | 9,330 | (9) | % | ||||||||||
Revenue growth in constant currency(1) | 1 | % | (6) | % | (1) | % | (5) | % | ||||||||||||||
Adjusted EBITDA(1) | ||||||||||||||||||||||
United States | $ | 167 | $ | 185 | (10) | % | $ | 367 | $ | 460 | (20) | % | ||||||||||
Japan | 113 | 113 | 0 | % | 228 | 254 | (10) | % | ||||||||||||||
Principal Markets | 57 | 62 | (9) | % | 157 | 134 | 17 | % | ||||||||||||||
Strategic Markets | 111 | 177 | (37) | % | 207 | 310 | (33) | % | ||||||||||||||
Corporate and other(2) | (20) | (37) | NM | (40) | (85) | NM | ||||||||||||||||
Total adjusted EBITDA(1) | $ | 428 | $ | 501 | (15) | % | $ | 919 | $ | 1,072 | (14) | % |
NM – not meaningful
(1) | Revenue growth in constant currency and adjusted EBITDA are non-GAAP financial metrics. See the information below for definitions of these metrics and a reconciliation of adjusted EBITDA to net income (loss). |
(2) | Represents net amounts not allocated to segments. |
We report our financial results in accordance with U.S. GAAP. We also present certain non-GAAP financial measures to provide useful supplemental information to investors. We provide these non-GAAP financial measures as we believe it improves visibility to underlying results and the impact of management decisions on operational performance and enables better comparison to peer companies.
Revenue growth in constant currency is a non-GAAP measure that eliminates the effects of exchange rate fluctuations when translating from foreign currencies to the United States dollar. It is calculated by using the average exchange rates that existed for the same period of the prior year. Constant-currency measures are provided so that revenue can be viewed without the effect of fluctuations in currency exchange rates, which is consistent with how management evaluates our revenue results and trends.
Additionally, management uses adjusted EBITDA to evaluate our performance. Adjusted EBITDA is a non-GAAP measure and defined as net income (loss) excluding net interest expense, depreciation and amortization (excluding depreciation of right-of-use assets and amortization of capitalized contract costs), pension costs other than pension servicing costs and multi-employer plan costs, early extinguishment of debt charges, workforce rebalancing and restructuring charges, transaction-related and integration-related items, goodwill and long-lived asset impairment charges, foreign currency impacts of highly inflationary countries, significant litigation costs, stock-based compensation expense and income taxes. We believe that adjusted EBITDA is a helpful supplemental measure to assist investors in evaluating our operating results as it excludes certain items whose fluctuation from period to period does not necessarily correspond to changes in the operations of our business. We provide this non-GAAP financial measure as we believe it improves visibility to underlying results and the impact of management decisions on operational performance, enables better comparison to peer companies and allows us to provide a long-term strategic view of the business.
32
Management Discussion (continued)
These disclosures are provided in addition to and not as a substitute for the percentage change in revenue and profit or loss measures on a U.S. GAAP basis compared to the corresponding period in the prior year. Other companies may calculate and define similarly labeled items differently, which may limit the usefulness of this measure for comparative purposes.
The following table provides a reconciliation of U.S. GAAP net income (loss) to adjusted EBITDA:
Three Months Ended September 30, | Six Months Ended September 30, | |||||||||||
(Dollars in millions) |
| 2022 |
| 2021 |
| 2022 |
| 2021 | ||||
Net income (loss) | $ | (281) | $ | (690) | $ | (531) | $ | (1,079) | ||||
Provision for income taxes | 61 | 224 | 107 | 300 | ||||||||
Workforce rebalancing charges (benefits) | 3 | (1) | 6 | (12) | ||||||||
Transaction-related costs | 68 | 270 | 171 | 443 | ||||||||
Stock-based compensation expense | 28 | 20 | 54 | 37 | ||||||||
Interest expense | 19 | 17 | 38 | 32 | ||||||||
Depreciation expense | 221 | 335 | 449 | 666 | ||||||||
Amortization expense | 301 | 321 | 609 | 672 | ||||||||
Other adjustments * | 9 | 7 | 18 | 14 | ||||||||
Adjusted EBITDA (non-GAAP) | $ | 428 | $ | 501 | $ | 919 | $ | 1,072 |
* | Other adjustments represent pension expense other than pension servicing costs and multi-employer plan costs. |
United States
| Three Months Ended | Year-over- |
| Six Months Ended | Year-over- | |||||||||||||||||
September 30, | Year | September 30, | Year | |||||||||||||||||||
(Dollars in millions) |
| 2022 | 2021 | Change |
| 2022 | 2021 | Change | ||||||||||||||
Revenue | $ | 1,149 | $ | 1,175 | (2) | % | $ | 2,317 | $ | 2,384 | (3) | % | ||||||||||
Adjusted EBITDA | 167 | 185 | (10) | % | 367 | 460 | (20) | % |
For the three months ended September 30, 2022, United States revenue of $1.1 billion decreased 2 percent compared to the prior-year quarter, primarily driven by reduced signings in the prior year. Adjusted EBITDA decreased $18 million from the prior-year quarter, primarily driven by lower revenues and certain software agreements moving from prepaid and amortized agreements to monthly subscription agreements.
For the six months ended September 30, 2022, United States revenue of $2.3 billion decreased 3 percent compared to the prior-year six-month period, primarily driven by reduced signings in the prior year. Adjusted EBITDA decreased $93 million from the prior-year six-month period, primarily driven by lower revenues and certain software agreements moving from prepaid and amortized agreements to monthly subscription agreements. The prior-year period also included a $27 million benefit from a previously-reserved-for customer collection.
Japan
| Three Months Ended | Year-over- |
| Six Months Ended | Year-over- | |||||||||||||||||
September 30, | Year | September 30, | Year | |||||||||||||||||||
(Dollars in millions) |
| 2022 | 2021 | Change |
| 2022 | 2021 | Change | ||||||||||||||
Revenue | $ | 614 | $ | 730 | (16) | % | $ | 1,249 | $ | 1,477 | (15) | % | ||||||||||
Revenue growth in constant currency | 6 | % | (2) | % | 3 | % | 0 | % | ||||||||||||||
Adjusted EBITDA | $ | 113 | $ | 113 | 0 | % | $ | 228 | $ | 254 | (10) | % |
For the three months ended September 30, 2022, Japan revenue of $614 million decreased 16 percent compared to the prior-year quarter. Revenue decreased due to an unfavorable currency exchange rate impact of 22 points. Adjusted
33
Management Discussion (continued)
EBITDA was unchanged from the prior-year quarter, reflecting unfavorable currency impacts, offset by lower costs from our post-Separation commercial agreements with IBM.
For the six months ended September 30, 2022, Japan revenue of $1.2 billion decreased 15 percent compared to the prior-year six-month period. Revenue decreased due to an unfavorable currency exchange rate impact of 18 points. Adjusted EBITDA decreased $26 million from the prior-year six-month period, primarily driven by unfavorable currency impacts, partially offset by lower costs from our post-Separation commercial agreements with IBM.
Principal Markets
| Three Months Ended | Year-over- |
| Six Months Ended | Year-over- | |||||||||||||||||
September 30, | Year | September 30, | Year | |||||||||||||||||||
(Dollars in millions) |
| 2022 | 2021 | Change |
| 2022 | 2021 | Change | ||||||||||||||
Revenue | $ | 1,472 | $ | 1,748 | (16) | % | $ | 2,988 | $ | 3,590 | (17) | % | ||||||||||
Revenue growth in constant currency | (5) | % | (6) | % | (7) | % | (5) | % | ||||||||||||||
Adjusted EBITDA | $ | 57 | $ | 62 | (9) | % | $ | 157 | $ | 134 | 17 | % |
For the three months ended September 30, 2022, Principal Markets revenue of $1.5 billion decreased 16 percent compared to the prior-year quarter. Revenue decreased due to certain joint ventures not transferring to us in connection with the Separation as well as an unfavorable currency exchange rate impact of 11 points, primarily driven by the strengthening of the U.S. dollar against the Euro and British pound. Adjusted EBITDA decreased $5 million from the prior-year period, driven by unfavorable currency exchange rate movements.
For the six months ended September 30, 2022, Principal Markets revenue of $3.0 billion decreased 17 percent compared to the prior-year six-month period. Revenue decreased due to certain joint ventures not transferring to us in connection with the Separation as well as an unfavorable currency exchange rate impact of 10 points, primarily driven by the strengthening of the U.S. dollar against the Euro and British pound. Adjusted EBITDA increased $23 million from the prior-year period, primarily due to lower costs from our post-Separation commercial agreements with IBM and despite headwinds from unfavorable currency exchange rates.
Strategic Markets
| Three Months Ended | Year-over- |
| Six Months Ended | Year-over- | |||||||||||||||||
September 30, | Year | September 30, | Year | |||||||||||||||||||
(Dollars in millions) |
| 2022 | 2021 | Change |
| 2022 | 2021 | Change | ||||||||||||||
Revenue | $ | 944 | $ | 926 | 2 | % | $ | 1,914 | $ | 1,879 | 2 | % | ||||||||||
Revenue growth in constant currency | 11 | % | (9) | % | 10 | % | (10) | % | ||||||||||||||
Adjusted EBITDA | $ | 111 | $ | 177 | (37) | % | $ | 207 | $ | 310 | (33) | % |
For the three months ended September 30, 2022, Strategic Markets revenue of $944 million increased 2 percent compared to the prior-year quarter driven by recent signings of incremental business, partially offset by a 9-point headwind from currency exchange rates, primarily the Euro. Adjusted EBITDA decreased $66 million from the prior-year quarter, since the majority of Strategic Markets countries were not charged for IBM software pre-Separation and software cost allocations began post-Separation.
For the six months ended September 30, 2022, Strategic Markets revenue of $1.9 billion increased 2 percent compared to the prior-year six-month period driven by recent signings of incremental business, partially offset by an 8-point headwind from currency exchange rates, primarily the Euro. Adjusted EBITDA decreased $103 million from the prior-year period, since the majority of Strategic Markets countries were not charged for IBM software pre-Separation and software cost allocations began post-Separation.
34
Management Discussion (continued)
Corporate and Other
Corporate and other had an adjusted EBITDA loss of $20 million in the three months ended September 30, 2022, compared to a loss of $37 million in the three months ended September 30, 2021. Corporate and other had an adjusted EBITDA loss of $40 million in the six months ended September 30, 2022, compared to a loss of $85 million in the six months ended September 30, 2021.
Costs and Expenses
Three Months Ended September 30, | Percent of Revenue | Change | |||||||||||||
(Dollars in millions) |
| 2022 | 2021 |
| 2022 | 2021 |
| 2022 vs. 2021 | |||||||
Revenue | $ | 4,179 | $ | 4,579 | 100.0 | % | 100.0 | % | (9) | % | |||||
Cost of services | 3,613 | 4,071 | 86.5 | % | 88.9 | % |
| (11) | % | ||||||
Selling, general and administrative expenses | 706 | 705 | 16.9 | % | 15.4 | % |
| 0 | % | ||||||
Workforce rebalancing charges (benefits) |
| 3 |
| (1) |
| 0.1 | % | 0.0 | % |
| NM | ||||
Transaction-related costs | 68 | 270 | 1.6 | % | 5.9 | % | (75) | % | |||||||
Interest expense |
| 19 |
| 17 |
| 0.4 | % | 0.4 | % |
| 10 | % | |||
Other expense (income) |
| (10) |
| (17) |
| (0.2) | % | (0.4) | % |
| NM | ||||
Income (loss) before income taxes | $ | (219) | $ | (466) |
|
|
|
|
NM – not meaningful
Cost of services was 86.5% of revenue in the three months ended September 30, 2022, compared to 88.9% in the three months ended September 30, 2021, primarily driven by benefits realized from structural actions taken in prior periods as well as lower costs from our post-Separation commercial agreements with IBM. Selling, general and administrative expenses were 16.9% of revenue in 2022 compared to 15.4% in 2021, driven by costs associated with operating as an independent public company and the impact of currency on revenue compared to our U.S. dollar-denominated expenses. Transaction-related costs were 1.6% of revenue in 2022 compared to 5.9% in 2021, primarily driven by higher employee-retention expense and pre-spin consultancy expense incurred in the prior year. Interest expense was 0.4% of revenue in 2022 compared to 0.4% in 2021, and includes interest expense associated with the indebtedness we incurred in connection with our Separation in the fourth quarter of 2021. Other expense (income) was (0.2)% of revenue in 2022 compared to (0.4)% in 2021, driven by hedging activity to partially offset the unfavorable impacts of currency movements of the U.S. dollar against other major currencies.
Six Months Ended September 30, | Percent of Revenue | Change | |||||||||||||
(Dollars in millions) |
| 2022 | 2021 |
| 2022 | 2021 |
| 2022 vs. 2021 | |||||||
Revenue | $ | 8,467 | $ | 9,330 | 100.0 | % | 100.0 | % | (9) | % | |||||
Cost of services | 7,290 | 8,233 | 86.1 | % | 88.2 | % |
| (11) | % | ||||||
Selling, general and administrative expenses | 1,400 | 1,419 | 16.5 | % | 15.2 | % |
| (1) | % | ||||||
Workforce rebalancing charges (benefits) |
| 6 |
| (12) |
| 0.1 | % | (0.1) | % |
| NM | ||||
Transaction-related costs | 171 | 443 | 2.0 | % | 4.7 | % | (61) | % | |||||||
Interest expense |
| 38 |
| 32 |
| 0.5 | % | 0.3 | % |
| 20 | % | |||
Other expense (income) |
| (13) |
| (6) |
| (0.2) | % | (0.1) | % |
| NM | ||||
Income (loss) before income taxes | $ | (425) | $ | (780) |
|
|
|
|
NM – not meaningful
Cost of services was 86.1% of revenue in the six months ended September 30, 2022, compared to 88.2% in the six months ended September 30, 2021, primarily driven by benefits realized from structural actions taken in prior periods as well as lower costs from our post-Separation commercial agreements with IBM. Selling, general and administrative expenses were 16.5% of revenue in 2022 compared to 15.2% in 2021, driven by costs associated with operating as an independent public company and the impact of currency on revenue compared to our U.S. dollar-denominated expenses. Transaction-related costs were 2.0% of revenue in 2022 compared to 4.7% in 2021, primarily driven by higher
35
Management Discussion (continued)
employee-retention expense and pre-spin consultancy expense incurred in the prior year. Interest expense was 0.5% of revenue in 2022 compared to 0.3% in 2021, and includes interest expense associated with the indebtedness we incurred in connection with our Separation in the fourth quarter of 2021. Other expense (income) was (0.2)% of revenue in 2022 compared to (0.1)% in 2021, driven by hedging activity to partially offset the unfavorable impacts of currency movements of the U.S. dollar against other major currencies.
Stock-Based Compensation
In the three months ended September 30, 2022, the Company granted equity and cash-based compensation awards to employees. These awards included 4 million restricted stock units that will vest ratably over four years; 2.4 million performance-conditioned stock units that are based on the attainment of operational milestones; and 0.7 million market-conditioned performance stock units that are based on the performance of the Company’s stock relative to that of its peers. Both types of performance-based awards will cliff vest based on the extent to which the performance criteria have been achieved as soon as practicable following the completion of the performance period on March 31, 2025. The total grant date fair value of the RSUs was determined using the stock price at the grant dates and will be recognized as stock-based compensation expense on a straight-line basis net of estimated forfeitures over the vesting period. The fair value of the performance-conditioned performance stock units ($10.62 per unit) was determined using the stock price at the grant date and will be adjusted and recognized as stock-based compensation expense based upon the probability of achievement of performance targets at each reporting period over the vesting period. The fair value of the market-conditioned performance stock units ($12.51 per unit) was determined at the grant date using a Monte Carlo simulation model and will be recognized as stock-based compensation expense on a straight-line basis net of estimated forfeitures over the vesting period. Dividend equivalents are not paid on the stock awards described above. The expense associated with these awards was $4 million during the three months ended September 30, 2022.
Transaction-Related Charges
The Company classifies certain expenses related to the Separation, acquisitions and divestitures (if any) as “transaction-related costs” in the Consolidated Income Statement. Transaction-related costs include expenditures incurred to prepare for and execute the Separation and establish Kyndryl as a standalone business. These costs include employee retention expenses, information technology costs, marketing expenses to establish the Kyndryl brand, legal, accounting, consulting and other professional service costs required to prepare for and execute the Separation. Transaction-related charges totaled $68 million and $270 million for the three months ended September 30, 2022 and 2021, respectively. Transaction-related charges totaled $171 million and $443 million for the six months ended September 30, 2022 and 2021, respectively.
Income Taxes
The provision for income taxes for the three months ended September 30, 2022 was $61 million of expense, compared to $224 million of expense for the three months ended September 30, 2021. The provision for income taxes for the six months ended September 30, 2022 was $107 million of expense, compared to $300 million of expense for the six months ended September 30, 2021. Our income tax expense for the three and six months ended September 30, 2022 was primarily related to taxes on foreign operations and the increase in valuation allowances, primarily in the United States, against deferred tax assets that are not more likely than not to be realized. Our income tax expense for the three and six months ended September 30, 2021 was primarily due to the geographic mix of pretax income, changes in valuation allowances and tax charges related to the transfer of Kyndryl’s operations from IBM in contemplation of the Company’s Separation.
In assessing the need for a valuation allowance, management considers all available evidence for each jurisdiction, including past operating results, estimates of future taxable income, the reversal of existing temporary differences and the feasibility of ongoing tax planning strategies and actions. Estimates of future taxable income and loss could change, perhaps materially, which may require us to revise our assessment of the recoverability of the deferred tax asset at that time.
36
Management Discussion (continued)
Financial Position
Dynamics
Total assets of $11.6 billion decreased by $1.8 billion (and decreased by $738 million adjusted for currency) from March 31, 2022, primarily driven by: a decrease of $692 million in accounts receivable due to collections and sales of accounts receivables outpacing additions to our receivables balance and currency impacts; a decrease in cash and cash equivalents of $246 million primarily due to currency impacts; a decrease in deferred costs of $258 million due to currency impacts and amortization outpacing additions as higher vendor billings for prepaid software typically occurred in the first calendar quarter; a decrease in property and equipment of $242 million due to currency impacts; and a decrease in operating right-of-use assets of $219 million due to payments, streamlining of office space and currency impacts.
Total liabilities of $9.9 billion decreased by $848 million (and decreased by $130 million adjusted for currency) from March 31, 2022, primarily as a result of: a decrease in accrued contract costs of $240 million due to timing of vendors billing Kyndryl for the first time as an independent company in the prior period; a decrease in deferred income of $235 million mainly due to the Company’s advanced annual billing with certain customers in the prior period and currency impacts; a decrease in operating lease liabilities of $210 million due to payments and currency impacts; and a decrease in retirement and nonpension postretirement benefit obligations of $91 million mainly due to currency impacts. Total equity of $1.7 billion decreased $1.0 billion from March 31, 2022 due to our comprehensive loss in the period.
Working Capital
September 30, | March 31, | |||||
(Dollars in millions) |
| 2022 |
| 2022 | ||
Current assets |
| $ | 4,964 |
| $ | 6,092 |
Current liabilities |
| 4,579 |
| 5,058 | ||
Working capital | $ | 385 | $ | 1,035 |
Working capital decreased $649 million from March 31, 2022. Current assets decreased $1.1 billion (and decreased $668 million adjusted for currency) primarily driven by: a decrease of $692 million in accounts receivable due to collections and sales of accounts receivables outpacing additions and currency impacts; and a decrease of $246 million in cash and cash equivalents primarily due to currency impacts. Current liabilities decreased $479 million (and decreased $8 million adjusted for currency) as a result of a decrease in current accrued contract costs of $240 million, and a decrease in deferred income (current) of $156 million due to advanced billing with certain customers in the prior period and currency impacts.
Noncurrent Assets and Liabilities
Noncurrent assets of $6.7 billion at September 30, 2022 decreased by $685 million (and decreased by $70 million adjusted for currency) compared to March 31, 2022, primarily driven by a decline in property and equipment of $242 million and a decline in right-of-use assets of $219 million.
Noncurrent liabilities of $5.3 billion at September 30, 2022 decreased $369 million (and decreased by $121 million adjusted for currency) compared to March 31, 2022, mainly driven by a decrease in operating lease liabilities (noncurrent portion) of $158 million and a decrease in retirement and nonpension postretirement benefit obligations of $91 million due to currency impacts.
37
Management Discussion (continued)
Cash Flow
Our cash flows from operating, investing and financing activities are summarized in the table below.
Six Months Ended September 30, | |||||||
(Dollars in millions) |
| 2022 |
| 2021 | |||
Net cash provided by (used in): |
|
|
| ||||
Operating activities | $ | 491 | $ | (397) | |||
Investing activities |
| (516) |
| (325) | |||
Financing activities |
| (69) |
| 1,432 | |||
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
| (160) |
| (9) | |||
Net change in cash, cash equivalents and restricted cash | $ | (253) | $ | 701 |
Net cash provided by operating activities was $491 million in the six months ended September 30, 2022, compared to net cash used of $397 million in the prior-year period. This change was driven by our reduced net loss and lower accounts receivable.
Net cash used by investing activities was $516 million in the six months ended September 30, 2022, compared to a net cash use of $325 million in the prior-year period. Capital expenditures consist of payments for property and equipment, and purchased and internally-developed software.
Net cash used by financing activities totaled $69 million in the six months ended September 30, 2022, compared to net cash provided by financing activities of $1.4 billion in the prior-year period. This change was driven by net transfers from former Parent of $1.3 billion in the prior-year period, which did not continue post-Separation, and proceeds of $140 million from a bank loan initiated in the prior-year period.
Other Information
Signings
The following table presents the Company’s signings for the three and six months ended September 30, 2022 and 2021.
| Three Months Ended September 30, |
| Six Months Ended September 30, | |||||||||
(Dollars in billions) |
| 2022 |
| 2021 |
| 2022 |
| 2021 | ||||
Total signings | $ | 2.5 | $ | 2.8 | $ | 5.4 | $ | 6.6 |
The following table presents the total contract value for the Company’s signings greater than $100 million for new and existing customers for the three and six months ended September 30, 2022 and 2021.
Three Months Ended September 30, | Six Months Ended September 30, | |||||||||||
(Dollars in millions) | 2022 | 2021 | 2022 | 2021 | ||||||||
New customers | $ | — | $ | — | $ | — | $ | — | ||||
Existing customers | $ | 443 | $ | 564 | $ | 818 | $ | 2,132 |
Signings decreased by $387 million, or 14%, for the three months ended September 30, 2022 compared to the prior-year period, primarily driven by a 9-point negative impact from currency. Signings decreased by $1,209 million, or 18%, for the six months ended September 30, 2022 compared to the prior-year six-month period, in part because our two largest signings in calendar 2021, aggregating $0.9 billion, both occurred in the quarter ended June 30, 2021. Additionally, currency had an 8-point negative impact to signings for the six months ended September 30, 2022. Management uses signings as a tool to monitor the performance of the business including the business’ ability to attract new customers and sell additional scope into our existing customer base. There are no third-party standards or
38
Management Discussion (continued)
requirements governing the calculation of signings. We define signings as an initial estimate of the value of a customer’s commitment under a contract. The calculation involves estimates and judgments to gauge the extent of a customer’s commitment, including the type and duration of the agreement and the presence of termination charges or wind-down costs. Contract extensions and increases in scope are treated as signings only to the extent of the incremental new value. Signings can vary over time due to a variety of factors including, but not limited to, the timing of signing a small number of larger outsourcing contracts. The conversion of signings into revenue may vary based on the types of services and solutions, customer decisions and other factors, which may include, but are not limited to, the macroeconomic environment or external events.
Liquidity and Capital Resources
We believe that our existing cash and cash equivalents and the Revolving Credit Agreement entered into in October 2021 will be sufficient to meet our anticipated cash needs for at least the next twelve months.
Senior Unsecured Notes
In October 2021, in preparation for our Spin-off, we completed the offering of $2.4 billion in aggregate principal amount of senior unsecured fixed-rate notes as follows: $700 million aggregate principal amount of 2.05% Senior Notes due 2026, $500 million aggregate principal amount of 2.70% Senior Notes due 2028, $650 million aggregate principal amount of 3.15% Senior Notes due 2031 and $550 million aggregate principal amount of 4.10% Senior Notes due 2041 (the “Notes”). The Notes were offered and sold to qualified institutional buyers in reliance on Rule 144A under the Securities Act and to non-U.S. persons in reliance on Regulation S of the Securities Act. The Notes are subject to customary affirmative covenants, negative covenants and events of default for financings of this type and are redeemable at our option in a customary manner.
In connection with the issuance of the Notes, we entered into a registration rights agreement with the initial purchasers of the Notes, pursuant to which we completed a registered offer to exchange each series of Notes for new notes with substantially identical terms during the quarter ended September 30, 2022.
Term Loan and Revolving Credit Facility
In October 2021, we entered into a $500 million three-year variable rate term loan credit agreement (the “Term Loan Credit Agreement”). In November 2021, we drew down the full $500 million available under the Term Loan Credit Agreement.
In October 2021, we entered into a $3.15 billion multi-currency revolving credit agreement (the “Revolving Credit Agreement” and, together with the Term Loan Credit Agreement, the “Credit Agreements”) for our future liquidity needs.
The Revolving Credit Agreement expires, unless extended, in October 2026, and the Term Loan Credit Agreement matures, unless extended, in November 2024. Interest rates on borrowings under the Credit Agreements are based on prevailing market interest rates, plus a margin, as further described in the Credit Agreements.
The Notes and the Credit Agreements were initially guaranteed by IBM. Approximately $900 million of the net proceeds from the term loan and the sale of the Notes was transferred to IBM in conjunction with the Separation. Following the completion of the Separation, the guarantee was released, and the Notes and the Credit Agreements are no longer obligations of IBM.
39
Management Discussion (continued)
We may voluntarily prepay borrowings under the Credit Agreements without premium or penalty, subject to customary “breakage” costs. The Credit Agreements include certain customary mandatory prepayment provisions. In addition, the Credit Agreements include customary events of default and affirmative and negative covenants as well as a maintenance covenant that will require that the ratio of our indebtedness for borrowed money to consolidated EBITDA (as defined in the Credit Agreements) for any period of four consecutive fiscal quarters be no greater than 3.50 to 1.00.
Transfers of Financial Assets
The Company has entered into agreements with third-party financial institutions to sell certain financial assets (primarily trade receivables) without recourse. The Company determined these are true sales, derecognized the carrying value of the financial asset transferred and recognized a net gain or loss on the sale. The agreement executed upon Separation enabled us to sell, at any one time, on a revolving basis, up to $1.1 billion of our trade receivables. The initial term of this agreement was 18 months, and the agreement automatically resets to a term of 18 months, after every six months, unless one of the parties elects not to extend. In the quarter ended June 30, 2022, the Company entered into an additional agreement, in which the sale of receivables is contingent on the approval of the counterparty with no defined facility limit. The initial term of this agreement is twelve months.
The proceeds from these arrangements are reflected as cash provided by operating activities in the Consolidated Statement of Cash Flows. Proceeds from receivables sold to third parties under this program were $722 million and $1.3 billion for the three and six months ended September 30, 2022, respectively. Prior to the Separation, the gross amount of the Company’s receivables sold to third parties and the financing division of our former Parent was $537 million and $1.3 billion for the three and six months ended September 30, 2021, respectively. The fees associated with the transfers of receivables were $12 million and $20 million for the three and six months ended September 30, 2022, respectively, and immaterial for the three and six months ended September 30, 2021, respectively.
Critical Accounting Estimates
The application of U.S. GAAP requires us to make estimates and assumptions about certain items and future events that directly affect our reported financial condition. There have been no changes to our critical accounting policies and estimates as described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (see Amendment No. 1 to our Current Report on Form 8-K/A filed with the SEC on May 27, 2022 (the “8-K/A”) for more information; we refer to the Annual Report on Form 10-K for the fiscal year ended December 31, 2021, revised and updated as set forth on Exhibit 99.1 to the 8-K/A, as the “Form 10-K”).
Cautionary Note Regarding Forward-Looking Statements
This report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this report, including statements concerning the Company’s plans, objectives, goals, beliefs, business strategies, future events, business condition, results of operations, financial position, business outlook and business trends and other non-historical statements in this report are forward-looking statements. Such forward-looking statements often contain words such as “will,” “anticipate,” “predict,” “project,” “contemplate,” “plan,” “forecast,” “estimate,” “expect,” “intend,” “target,” “may,” “should,” “would,” “could,” “seek,” “aim” and other similar words or expressions or the negative thereof or other variations thereon. Forward-looking statements are based on the Company’s current assumptions and beliefs regarding future business and financial performance. The Company’s actual business, financial condition or results of operations may differ materially from those suggested by forward-looking statements as a result of risks and uncertainties which include, among others:
● | risks related to the Company’s spin-off from IBM; |
● | failure to attract new customers, retain existing customers or sell additional services to customers; |
● | technological developments and the Company’s response to such developments; |
● | failure to meet growth and productivity objectives; |
40
Management Discussion (continued)
● | competition; |
● | impacts of relationships with critical suppliers; |
● | inability to attract and retain key personnel and other skilled employees; |
● | impact of local legal, economic, political, health and other conditions, including the COVID-19 pandemic; |
● | a downturn in economic environment and customer spending budgets; |
● | damage to the Company’s reputation; |
● | inability to accurately estimate the cost of services and the timeline for completion of contracts; |
● | service delivery issues; |
● | the Company’s ability to successfully manage acquisitions, alliances and dispositions, including integration challenges, failure to achieve objectives, the assumption of liabilities, and higher debt levels; |
● | the impact of our business with government customers; |
● | failure of the Company’s intellectual property rights to prevent competitive offerings and the failure of the Company to obtain necessary licenses; |
● | risks relating to cybersecurity and data privacy; |
● | adverse effects from tax matters and environmental matters; |
● | legal proceedings and investigatory risks; |
● | impact of changes in market liquidity conditions and customer credit risk on receivables; |
● | the Company’s pension plans; |
● | the impact of foreign currency fluctuations; and |
● | risks related to the Company’s common stock and the securities market. |
Additional risks and uncertainties include, among others, those risks and uncertainties described in the “Risk Factors” section of our Form 10-K, as such factors may be updated from time to time in the Company’s periodic filings with the SEC. Any forward-looking statement in this report speaks only as of the date on which it is made. Except as required by law, the Company assumes no obligation to update or revise any forward-looking statements.
Website and Social Media Disclosure
The Company may use its website and/or social media outlets, such as Facebook, LinkedIn and Twitter, as distribution channels of material company information. Financial and other important information regarding the Company is routinely posted on and accessible through the Company’s website at https://investors.kyndryl.com, its Facebook page at https://www.facebook.com/kyndryl, its LinkedIn page at https://linkedin.com/company/kyndryl and its Twitter account (@Kyndryl) at https://twitter.com/Kyndryl. In addition, you may automatically receive email alerts and other information about the Company when you enroll your email address by visiting the “Investor Email Alerts” section under the “Resources” section at https://investors.kyndryl.com.
41
Item 3. Quantitative and Qualitative Disclosures About Market Risk
For our disclosures about market risk, see the information under the heading “Quantitative and Qualitative Disclosures About Market Risk” in the Form 10-K. There have been no material changes to the Company’s disclosure about market risk in the Form 10-K.
Item 4. Controls and Procedures
The Company’s management evaluated, with the participation of the Chief Executive Officer and Chief Financial Officer, the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report.
There has been no change in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) of the Exchange Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
42
Part II — Other Information
Item 1. Legal Proceedings
Refer to Note 10 – Commitments and Contingencies, in the notes to consolidated financial statements in this report.
Item 1A. Risk Factors
For a discussion of our potential risks and uncertainties, see the information under the heading “Risk Factors” in the Form 10-K. There have been no material changes with respect to the risk factors disclosed in the Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
43
Item 6. Exhibits
Exhibit Number | Description of Exhibit |
2.1 | |
3.1 | |
3.2 | |
10.1 | |
10.2 | |
10.3 | Form of LTPP equity award agreement for performance share units (Fiscal 2023) |
31.1 | |
31.2 | |
32.1 | |
32.2 | |
101.INS | XBRL Instance Document – the instance document does not appear on the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
101.SCH | XBRL Taxonomy Extension Schema Document |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
104 | Cover Page Interactive Data File – the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular, any representations and warranties made by the Company in these agreements or other documents were made solely within the specific context of the relevant agreement or document and do not apply in any other context or at any time other than the date they were made.
44
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Kyndryl Holdings, Inc. | ||||
(Registrant) | ||||
Date: | November 4, 2022 | |||
By: | /s/ Vineet Khurana | |||
Vineet Khurana | ||||
Vice President and Controller (Principal Accounting Officer and Authorized Signatory) |
45
Exhibit 10.3
Form of
Kyndryl
Equity Award Agreement
Plan | Kyndryl 2021 Long-Term Performance Plan (the “Plan”) |
Award Type | Performance Share Units (PSUs) |
Purpose | The purpose of this Award is to retain selected executives. You recognize that this Award represents a potentially significant benefit to you and is awarded for the purpose stated here. |
Awarded to | Sample |
Award Agreement | This Equity Award Agreement, together with the “Terms and Conditions of Your Equity Award Effective November 3, 2021” (“Terms and Conditions”) document and the Plan http://w3.kyndryl.net/hr/web/compensation/executive/eq_prospectus/, both of which are incorporated herein by reference, together constitute the entire agreement between you and Kyndryl with respect to your Award. |
Grant | Date of Grant | Business | Business | # PSUs | Performance Period | Date of Payout |
| August 1, | Adjusted | 50% | [] | April 1, 2022 - | May 30, 2025 |
| August 1, | Total | 25% | [] | April 1, 2022 - | May 30, 2025 |
| August 1, | Relative | 25% | [] | April 1, 2022 - | May 30, 2025 |
Vesting | You can earn the PSUs awarded above based on Kyndryl’s performance in achieving the business targets approved by the Committee and described on Exhibit A during the performance period beginning on April 1, 2022 and ending on March 31, 2025 (the “Performance Period”). |
Payout of Awards | On the “Date of Payout” indicated above, the Company shall either (a) deliver to you a number of shares of Common Stock equal to the number of your earned PSUs, or (b) make a cash payment to you equal to the Fair Market Value on the Date of Payout of the number of your earned PSUs at the end of the Performance Period, in either case, net of any applicable tax withholding, and the respective PSUs shall thereafter be cancelled. |
| All payouts under this Award are subject to the provisions of the Plan, this Agreement and the Terms and Conditions document, including those relating to the cancellation and rescission of awards. |
Page 1 of 3
Kyndryl Confidential
Kyndryl
Equity Award Agreement
Terms and Conditions of Your Equity Award | Refer to the Terms and Conditions document attached for an explanation of the terms and conditions applicable to your Award, including those relating to: ·Cancellation and rescission of awards (also see below) ·Jurisdiction, governing law, expenses and taxes ·Non-solicitation of Company employees and clients, if applicable ·Treatment of your Award in the event of death or disability or leave of absence · Treatment of your Award upon termination of employment It is strongly recommended that you print the Terms and Conditions document for later reference. |
Cancellation and Rescission | You understand that Kyndryl may cancel, modify, rescind, suspend, withhold or otherwise limit or restrict this Award in accordance with the terms of the Plan, including, without limitation, canceling or rescinding this Award if you render services for a competitor prior to, or during the Rescission Period. You understand that the Rescission Period that has been established is 12 months. Refer to the Terms and Conditions document and the Plan for further details. |
Data Privacy, Electronic Delivery | By accepting this Award, you agree that data, including your personal data, necessary to administer this Award may be exchanged among Kyndryl and its subsidiaries and affiliates as necessary, and with any vendor engaged by Kyndryl to administer this Award, subject to the Terms and Conditions document; you also consent to receiving information and materials in connection with this Award or any subsequent awards under Kyndryl’s long-term performance plans, including without limitation any prospectuses and plan documents, by any means of electronic delivery available now and/or in the future (including without limitation by e-mail, by Web site access and/or by facsimile), such consent to remain in effect unless and until revoked in writing by you. |
Extraordinary Compensation | Your participation in the Plan is voluntary. The value of this Award is an extraordinary item of income, is not part of your normal or expected compensation and shall not be considered in calculating any severance, redundancy, end of service payments, bonus, long-service awards, pension, retirement or other benefits or similar payments. The Plan is discretionary in nature. This Award is a one-time benefit that does not create any contractual or other right to receive additional awards or other benefits in the future. Future grants, if any, are at the sole grace and discretion of Kyndryl, including but not limited to, the timing of the grant, the number of units and vesting provisions. This Equity Award Agreement is not part of your employment agreement, if any. Nothing in the Plan, in the grant of any Award or in this Equity Award Agreement shall confer upon you any right to continued employment with Kyndryl or any of its subsidiaries or affiliates, or interfere in any way with the right of Kyndryl or any of its subsidiaries or affiliates to terminate you employment or other service relationship for any reason at any time. |
Page 2 of 3
Kyndryl Confidential
Kyndryl
Equity Award Agreement
Accept Your Award | This Award is considered valid when you accept it. This Award will be cancelled unless you accept it by 11:59 p.m. Eastern time two business days prior to the end of the Performance Period in the “Grant” section of this Agreement. By pressing the Accept button below to accept your Award, you acknowledge having received and read this Equity Award Agreement, the Terms and Conditions document and the Plan under which this Award was granted and you agree (i) not to hedge the economic risk of this Award or any previously-granted outstanding awards, which includes entering into any derivative transaction on Kyndryl securities (e.g., any short sale, put, swap, forward, option, collar, etc.), (ii) to comply with the terms of the Plan, this Equity Award Agreement and the Terms and Conditions document, including those provisions relating to cancellation and rescission of awards and jurisdiction and governing law, and (iii) that by your acceptance of this Award, all awards previously granted to you under the Plan or other Kyndryl Long-Term Performance Plans are subject to any cancellation, rescission or recovery required by applicable laws, rules, regulations or standards, including without limitation any requirements or standards of the U.S. Securities and Exchange Commission or the New York Stock Exchange. |
Page 3 of 3
Kyndryl Confidential
Kyndryl
Exhibit A to Equity Award Agreement
Vesting; Calculating Achievement of Performance Criteria
You can earn the PSUs awarded above based on Kyndryl’s performance in achieving during the Performance Period the performance criteria set forth in materials presented to and approved by the Committee and described below. As soon as practicable following the completion of the Performance Period, the Committee shall determine, in its sole discretion, the achievement with respect to each of the performance criteria described below and will calculate the “% of Target Payout” based on the actual level of achievement of each of the performance criteria. The performance criteria shall not be achieved and no PSUs shall be vested until the Committee certifies in writing the extent to which the performance criteria have been achieved. All determinations with respect to whether, and the extent to which, the performance criteria have been achieved shall be made by the Committee in its sole discretion.
The number of PSUs that are eligible to be earned shall be based on the Committee’s certification of the achievement of the performance criteria established by the Committee, with the number of PSUs earned in respect of achievement of each of the performance criteria equal to the product of (1) the target number of PSUs awarded multiplied by the weighting for each performance criteria set forth below, times (2) the applicable “% of Target Payout” achieved with respect to each of the performance criteria. The number of PSUs earned shall be rounded up or down to the nearest whole PSU.
If the actual performance with respect to a performance criteria determined by the Committee is between (i) the “Threshold” and “Target” or “Target Range” (as applicable) levels of achievement or (ii) the “Target” or “Target Range” (as applicable) and “Maximum” levels of achievement, then the “% of Target Payout” shall be determined by linear interpolation (and rounded to the nearest tenth of a whole percent).
Any PSUs that do not become vested based on the actual achievement of the performance criteria during the Performance Period will be forfeited for no consideration therefor as of the Date of Payout.
Performance Criteria
I.Adjusted Operating Cash Flow - 50% Weighting
“Adjusted Operating Cash Flow” means cash flow from operations with the following add-backs: separation-related costs, workforce rebalancing and restructuring charges, transaction-related and integration-related items, goodwill and long-lived asset impairment charges, foreign currency impacts of highly inflationary countries, significant litigation costs, amortization of intangible assets, stock-based compensation, and pension costs other than pension servicing costs and multi-employer plan costs.
Level of Achievement | Below Threshold | Threshold | Target | Maximum |
Page 1 of 4
Kyndryl Confidential
Goal Attainment % | < 80% | 80% | 100% | 120% |
% of Target Payout | 0% | 50% | 100% | 150% |
II.Total Signings - 25% Weighting
“Signings” means an initial estimate of the value of a customer’s commitment under a contract.
“Total Signings” means the aggregate amount of all Signings during the Performance Period.
Level of Achievement | Below Threshold | Threshold | Target Range | Maximum | ||
Goal Attainment % | < 80% | 80% | 98% | 100% | 102% | 120% |
% of Target Payout | 0% | 20% | 100% | 100% | 100% | 150% |
III.Relative Total Shareholder Return - 25% Weighting
A portion of the PSUs awarded to you are eligible to be earned based on the percentile rank of Kyndryl’s total shareholder relative to the comparison group of companies (the “Peer Group,” and each member thereof, a “Peer Company” and such percentile rank, “Relative TSR”). For purposes of determining Relative TSR, the Peer Group will consist of the constituents of the S&P 400 Mid-Cap Index as of April 1, 2022, provided that a constituent company that ceases to be a member of the S&P Mid-Cap Index after April 1, 2022 will cease to be a member of the Peer Group.
The number of PSUs that shall be eligible to vest based on the achievement of Relative TSR (as defined below) is set forth in the table below.
Level of Achievement | Below Threshold | Threshold | Target | Maximum |
Goal Attainment Percentile | < 25th percentile | 25th percentile | 50th percentile | 90th percentile |
% of Target Payout | 0% | 50% | 100% | 200% |
Each Peer Company’s total shareholder return (“TSR”) will be measured over the Performance Period using the following equation:
Page 2 of 4
Kyndryl Confidential
“Adjusted End Price” means the average closing stock price of the five trading days ending on the last day of the Performance Period. Dividends are assumed to be reinvested in additional shares of the issuing entity’s stock as of the ex-dividend date.
“Start Price” means the average closing stock price of the five trading days ending on the first day of the Performance Period.
At the end of the Performance Period, the TSR of each Peer Company (excluding Kyndryl) will be ranked from highest to lowest, with the Peer Company with the highest TSR being assigned the rank of one. The percentile rank of the Peer Company with the TSR closest to, but greater than, Kyndryl’s TSR and the Peer Company with the TSR closest to, but less than, Kyndryl’s TSR will be calculated using the equation below, where N is the total number of Peer Companies, excluding Kyndryl, and R is a Peer Company’s ranking within the comparison group, excluding Kyndryl:
The percentile rank of Kyndryl’s TSR against the comparison group will be calculated using the equation below, where PKD and TSRKD equal Kyndryl’s percentile rank and TSR, respectively; Pabove and TSRabove equal the percentile rank and TSR, respectively, for the Peer Company whose TSR ranks immediately above Kyndryl; and Pbelow and TSRbelow equal the percentile rank and TSR, respectively, for the Peer Company whose TSR ranks immediately below Kyndryl.
If Kyndryl’s TSR is greater than the TSR of the Peer Company that ranked first within the comparison group, Kyndryl’s TSR will be positioned at the 100th percentile. Similarly, if Kyndryl’s TSR is less than the TSR of the Peer Company that ranked last within the comparison group, Kyndryl’s TSR will be positioned at the 0th percentile.
Notwithstanding the foregoing, if Kyndryl’s TSR at the end of the Performance Period is negative, the “% of Target Payout” in respect of Relative TSR will be capped at 100%.
A member of the Peer Group will be removed if: (i) during the Performance Period, the constituent company makes a public disclosure of its intent or agreement to enter into a merger or sale with another company, after which the constituent company will no longer be listed on a securities exchange; or (ii) it is not listed on a securities exchange for the entire Performance Period; provided, that a company that becomes subject to a proceeding as a debtor under the U.S. Bankruptcy Code during the Performance Period will be included with TSR equal to -100%.
Adjustments to Performance Criteria
Adjustments to the performance criteria will be determined by the Committee in accordance with the established adjustment policy, which includes (among others):
· | Currency impacts – predetermined financial results are updated to remove the impact from currency movements; |
Page 3 of 4
Kyndryl Confidential
· | Unplanned acquisitions or divestitures; |
· | Novation – loss of non-novated contracts over the 12- to 15-month period following the commencement of the Performance Period; |
· | Special items as disclosed in Kyndryl’s public financial reporting, including but not limited to, gains/losses on divestitures or asset sales, effect of changes in accounting principles, tax law, or other laws or provisions affecting reported results; |
· | Material changes to commercial agreements driven by a change in IBM strategy; or |
· | Cash usage associated with the deployment of any long-term incentive cash-deferred plans. |
The Committee shall have the discretion to determine whether, when and to what extent an adjustment is necessary or advisable based upon consideration of such factors the Committee deems appropriate in light of the facts and circumstances.
Notwithstanding the foregoing, no adjustments will be made to performance criteria due to planned acquisitions or divestitures or customer terminations or loss of scope (excluding loss of non-novated contracts).
Page 4 of 4
Kyndryl Confidential
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
I, Martin J. Schroeter, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Kyndryl Holdings, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 4, 2022
| /s/ Martin J. Schroeter |
| Martin J. Schroeter |
| Chairman and Chief Executive Officer |
| (Principal Executive Officer) |
Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
I, David B. Wyshner, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Kyndryl Holdings, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 4, 2022
| /s/ David B. Wyshner |
| David B. Wyshner |
| Chief Financial Officer |
| (Principal Financial Officer) |
Exhibit 32.1
KYNDRYL HOLDINGS, INC.
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Kyndryl Holdings, Inc. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Martin J. Schroeter, Chairman and Chief Executive Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 4, 2022
| /s/ Martin J. Schroeter |
| Martin J. Schroeter |
| Chairman and Chief Executive Officer |
| (Principal Executive Officer) |
Exhibit 32.2
KYNDRYL HOLDINGS, INC.
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Kyndryl Holdings, Inc. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David B. Wyshner, Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 4, 2022
| /s/ David B. Wyshner |
| David B. Wyshner |
| Chief Financial Officer |
| (Principal Financial Officer) |